Allianz SE ALV.DE
Quarterly and annual results for Allianz stock (ALV.DE) since 2023: revenue, earnings, balance sheet, cash flow and management guidance from IR documents, every figure with its source. As of 08/2026, quarterly reporting. Latest reported (Q2 2026): Schaden-Kosten-Quote, Neugeschäftsmarge, Für Dritte verwaltetes Vermögen. Latest reading: Margin expanding, Acquisition, Operating income turned positive.
Published by Michael Wirl · About us · Methodology
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Business Model#
What the company does and how it earns its money; written AI-editorially, exclusively from the company's original reports, without any assessment of our own.
Allianz SE is one of the world's largest financial services groups, operating through three core segments: Property-Casualty insurance, Life/Health insurance, and Asset Management. Insurance premiums and policy fees constitute the primary recurring revenue streams in the insurance segments, with underwriting profitability measured through the combined ratio in Property-Casualty and new business margin metrics in Life/Health. The Asset Management segment, principally PIMCO and Allianz Global Investors, earns management and performance fees on assets managed for third parties globally. The Group also generates income from proprietary investment portfolios, strategic equity holdings, and distributions from minority interests in financial services entities such as Viridium and Sconset Re.
Current Status#
Summary of the most recent reporting period: core figures, drivers and management statements; written editorially from the current original report, every figure backed by a source number.
Price & Chart#
Interactive price chart (TradingView) and the trend of key figures from the core tables. The price chart loads only after a click; at that point a connection to TradingView is established.
Daily candles with news and earnings markers. Loads only on click.
Share-Price Drivers#
Factors the company itself names as material for its business development (IR-based); reproduced neutrally, no price forecast and no assessment of our own.
Property-Casualty Insurance Operations produced the largest segment revenue in the first half of 2026 and grew year on year, carrying group net income 31
H1 2026 Property-Casualty operations revenue grew 5.6% year on year with an operating margin of 9.8% 31
H1 2026 Life/Health operations revenue was broadly stable, up 1.6% year on year 31, while German Life/Health premiums were lower 36
planned acquisitions of HSBC Life Singapore and UOB Asset Management (UOBAM) are set to add to the Asset Management franchise 31
a new share buy-back program of up to EUR 2.5 billion 29 alongside an ongoing buy-back program 31
second-quarter net income of 2,940 with diluted EPS of 6.66 came in higher than the prior-year quarter 31
Sector trend: Across the insurance operations, Property-Casualty revenue is rising with an operating margin near 9.8%, while Life/Health revenue is broadly stable and German Life/Health premiums are lower; Asset Management is being expanded through acquisitions 31 36.
Event Timeline#
This timeline collects the material events from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements. Events are grouped by quarter (most recent first); the grey tag before each event names the event type, the date is the publication date of the source. Management quotes open the quarter block as direct quotes. Per quarter we show the three most defining events; more can be expanded per quarter, older years are collapsed. Every event carries its source as a superscript, clickable number.
2026 · 6 events
2026-Q2 · Apr – Jun 2026
Q2 2026 operating profit rose 10.6% to record €4,874 mn; H1 2026 operating profit up 8.6% to €9,390 mn 36
Property-Casualty combined ratio of 91.9% in Q2 2026 and 91.4% for H1 2026, both below full-year guidance of 92-93% 36
Agreement announced to acquire HSBC Life Singapore for €2.0 bn combined consideration with 15-year exclusive distribution partnership 31
2026-Q1 · Jan – Mar 2026
Completed sale of 26% stake in Bajaj joint ventures BAGIC and BALIC to Bajaj Promotor Group for approximately €2.3 bn; non-operating pre-tax gain of €1.3 bn recognized in Q1 2026 31
Q1 2026 operating profit rose 6.6% to record €4,517 mn, with Property-Casualty reaching an operating record of €2.4 bn 34
2025 · 12 events
2025-Q4 · Oct – Dec 2025
Record FY 2025 operating profit of EUR 17,374 million, up 8.4% from EUR 16,023 million in 2024, exceeding full-year guidance 26
Property-Casualty combined ratio improved to 92.2% in FY 2025 from 93.4% in 2024, driven by lower claims and underwriting measures 27
FY 2026 operating profit guidance initiated at EUR 17.4 billion plus or minus EUR 1.0 billion 27
2025-Q3 · Jul – Sep 2025
Property-Casualty combined ratio improved to 91.9% in Q3 and 91.6% in 9M 2025 from 93.5% and 93.0% respectively in the prior-year periods 25
9M 2025 operating profit increased to EUR 13.1 billion from EUR 11.8 billion in 9M 2024 19
Full-year 2025 operating profit outlook raised to at least EUR 17.0 billion, the upper end of the original guidance range 19
2025-Q2 · Apr – Jun 2025
H1 operating profit increased 9.3% to EUR 8.6 billion, reaching a record half-year level 18
Property-Casualty combined ratio improved to 91.5% in H1 2025 from 92.7% in H1 2024, driven by price increases and better claims experience 18
Sale of 50% stake in UniCredit Allianz Vita S.p.A. completed on 20 June 2025 18
2025-Q1 · Jan – Mar 2025
Record Q1 operating profit of EUR 4.2 billion reported 21
Full-year operating profit guidance confirmed at EUR 16.0 billion plus or minus EUR 1.0 billion 21
2024 · 12 events
2024-Q4 · Oct – Dec 2024
Full-year operating profit reached a record €16.0 bn, up 8.7%, exceeding the target range; Q4 operating profit rose 10.9% to €4.2 bn 51
Full-year Property-Casualty combined ratio improved to 93.4% from 93.8% in 2023, within guidance range of approximately 93%-94% 53
2025 operating profit target of €16.0 bn ± €1 bn announced, anchoring the new 2025-2027 planning cycle 51
2024-Q3 · Jul – Sep 2024
Q3 operating profit grew 13.6% to €3.9 bn, mainly driven by Property-Casualty; 9M operating profit up 7.9% 14
Management expects 2024 operating profit in upper half of target range of €14.8 bn ± €1 bn 14
2024-Q2 · Apr – Jun 2024
H1 operating profit increased 5.3% to €7,911 mn, with positive contributions from all business segments 10
Property-Casualty combined ratio increased 0.7 percentage points to 92.7% due to higher claims inflation 10
Acquisition of 99.99% of TUA Assicurazioni S.p.A. completed on 1 March 2024, consolidating Property-Casualty position in Italy 10
2024-Q1 · Jan – Mar 2024
Operating profit rose 6.8% to €4.0 bn, driven by Property-Casualty, Asset Management, and Life/Health 11
Full-year 2024 operating profit target of €14.8 bn ± €1 bn confirmed 11
2023 · 10 events
2023-H1 · Jan – Jun 2023
Operating profit increased to €7,513M in H1 from €6,536M in H1 2022, mainly driven by Life/Health and Property-Casualty segments 2
Total business volume rose 6.4% on an internal basis in H1, driven by Property-Casualty positive price and volume effects 2
Allianz completed acquisition of Innovation Group Holdings Ltd. on 12 January 2023, recognizing €270M in goodwill, a global provider of claims and technology solutions 2
2023-Q4 · Oct – Dec 2023
Full-year operating profit increased 6.7% to €14.7B, exceeding the annual target; Property-Casualty, Life/Health, and Corporate segments all contributed to growth 61
2024 operating profit target set at €14.8B ±€1B; new share buyback program of up to €1.0B announced for start in March 2024 58
Core return on equity improved to 16.0% in 2023 from 12.7% in 2022, reflecting full-year operating and net income growth 9
Allianz formed partnership with Sanlam Ltd., contributing African business operations in exchange for a 41% shareholding in the combined entity 62
2023-Q3 · Jul – Sep 2023
Q3 operating profit fell 14.6% to €3.5B, impacted by exceptionally high natural catastrophe claims; nine-month cumulative operating profit still up 3.6% to €11.0B 6
Property-Casualty combined ratio rose 3.7 percentage points to 96.2% in Q3, driven by extraordinary natural catastrophe claims 6
FY2023 operating profit target of €14.2B (±€1B) confirmed despite the nat-cat-heavy quarter 6
Key Figures (€m)#
The company's core financial figures in three views, one below the other: fiscal years (as reported; after restatements the table shows the most recent filing version, marked), half-years (6-month basis, H2 = second half on its own) and quarters (3-month basis, not cumulative). Each row is one period, most recent first. Values with a dotted underline are clickable and show the raw value, the exact source location, the scale evidence and the source; derived values additionally show their formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Revenue | Net income | EPS (€) | EPS adj. (€) | OCF | Source |
|---|---|---|---|---|---|---|
| FY2025 | 102,802 | 11,430~ | 27.67 | 28.61 | 33,209 | 154 |
| FY2024 | 97,675 | 10,540~ | 25.18 | 25.42 | 31,903 | 132 |
| FY2023 | 91,251 | 9,032 | 21.18 | – | 24,462 | 162 |
Half-years
| Period | Published | Revenue | Net income | EPS (€) | EPS adj. (€) | Cash | Source |
|---|---|---|---|---|---|---|---|
| 2026-H1 | 2026-06-30 | 53,125 | 6,630~ | 16.12 | 16.44 | 27,319 | 135 |
| 2025-H2* | 2025-06-30 | 52,628 | 6,166 | 14.93*≈ | – | 29,854 | 135 |
| 2025-H1 | 2025-06-30 | 50,174 | 5,264 | 13.30 | 14.00 | 33,886 | 36 |
| 2024-H2* | 2024-08-07 | 50,389 | 5,247 | 12.54*≈ | – | 31,637 | 132 |
| 2024-H1 | 2024-08-07 | 47,286 | 5,293 | 12.40 | 12.57 | 28,058 | 10 |
| 2023-H2* | 2023-08-08 | 46,770 | 4,385 | 10.28*≈ | – | 29,210 | 119 |
| 2023-H1 | 2023-08-08 | 44,481~ | 4,647 | 10.58 | 11.40 | 25,612 | 2 |
Quarters
| Period | Published | Revenue | Net income | EPS (€) | EPS adj. (€) | Cash | Source |
|---|---|---|---|---|---|---|---|
| 2026-Q2* | 2026-06-30 | – | 2,940 | 6.66*≈ | – | 27,319 | 31 |
| 2026-Q1* | 2026-03-31 | – | 3,690 | 9.96≈ | – | – | 33 |
| 2025-Q4 | 2025-06-30 | – | 2,664 | 6.98 | 7.17 | 29,854 | 46 |
| 2025-Q2* | 2025-08-07 | – | 2,841 | 7.39≈ | 7.39° | 33,886 | 23 |
| 2025-Q1* | 2025-05-15 | – | 2,423 | 6.61≈ | 6.61 | – | 21 |
| 2024-Q4 | 2024-06-30 | 25,819 | 2,636 | 6.40 | 6.31 | 31,637 | 53 |
| 2024-Q3* | 2024-11-13 | – | -2,822 | -6.74*≈ | – | – | 14 |
| 2024-Q2* | 2024-08-07 | – | 2,818 | 6.73*≈ | – | 28,058 | 10 |
| 2024-Q1* | 2024-05-15 | – | 2,475 | 6.42≈ | – | – | 11 |
| 2023-Q4 | 2023-06-30 | 23,748 | 2,151 | 5.47 | – | 29,210 | 54 |
| 2023-Q3* | 2024-11-13 | – | 1,743 | 4.09*≈ | – | – | 14 |
Balance Sheet & Cash Flow (€m)#
Point-in-time balance sheet items (e.g. cash, financial debt) and cash flow items (operating cash flow, investments/capex) per fiscal year, half-year and quarter. Balance sheet values are as of the period end, flow items cover the period. Derived values are marked and are calculated, for example, as: net debt = financial debt − cash; free cash flow = operating cash flow − capex; the click popover shows formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
Fiscal years
| Period | Published | Cash | OCF | Source |
|---|---|---|---|---|
| FY2025 | 2025-06-30 | 29,854 | 33,209 | 154 |
| FY2024 | 2024-06-30 | 31,637 | 31,903 | 132 |
| FY2023 | 2023-06-30 | 29,210 | 24,462 | 162 |
Half-years
| Period | Published | Cash | OCF | Source |
|---|---|---|---|---|
| 2026-H1 | 2026-06-30 | 27,319 | 16,917 | 135 |
| 2025-H2 | 2025-06-30 | 29,854 | 13,074 | 135 |
| 2025-H1 | 2025-06-30 | 33,886 | 20,135 | 36 |
| 2024-H2 | 2024-08-07 | 31,637 | 16,636 | 132 |
| 2024-H1 | 2024-08-07 | 28,058 | 15,267 | 10 |
| 2023-H2 | 2023-08-08 | 29,210 | 10,102 | 119 |
| 2023-H1 | 2023-08-08 | 25,612 | 14,360 | 2 |
Quarters
| Period | Published | Cash | OCF | Source |
|---|---|---|---|---|
| 2026-Q2 | 2026-06-30 | 27,319 | – | 31 |
| 2025-Q4 | 2025-06-30 | 29,854 | – | 46 |
| 2025-Q2 | 2025-08-07 | 33,886 | – | 23 |
| 2024-Q4 | 2024-06-30 | 31,637 | – | 53 |
| 2024-Q2 | 2024-08-07 | 28,058 | – | 10 |
| 2023-Q4 | 2023-06-30 | 29,210 | 9,935 | 54 |
Revenue by Type (as of 2026-Q2 · EURm · 34/80)#
Revenue split by segment or product type, exactly as the company itself reports it. The basis is stated next to each value (3, 6 or 12 months); segment totals can deviate from group revenue (reconciliation/consolidation items). If the company changes its segment structure, older structures are kept in the expandable part. Rows in grey are no longer reported separately by the company; they show the last available figures and are never extrapolated.
| Segment | Since | Period | Basis | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|---|---|
| Asset Management | FY2022 | 2026-H1 | 6M | 4,512 | – | – | 31 |
| Property-Casualty | 2026-Q1 | 2026-Q1 | 3M | 28,300 | 4% | – | 33 |
| Life reinsurance | FY2025 | FY2025 | 12M | 532 | -5.9% | – | 28 |
| Non-Life – Germany | 2025-Q4 | 2025-Q4 | 12M | 1,505.3 | – | – | 48 |
| Life – Germany Life | 2025-Q4 | 2025-Q4 | 12M | 1,192.3 | – | – | 48 |
| Life – France | 2025-Q4 | 2025-Q4 | 12M | 644.8 | – | – | 48 |
| Non-Life – Western & Southern Europe (excl. Top 5) | 2025-Q4 | 2025-Q4 | 12M | 625.3 | – | – | 48 |
| Life – Asia-Pacific | 2025-Q4 | 2025-Q4 | 12M | 603 | – | – | 48 |
| Life – Central Europe | 2025-Q4 | 2025-Q4 | 12M | 588.2 | – | – | 48 |
| Non-Life – Italy | 2025-Q4 | 2025-Q4 | 12M | 503.1 | – | – | 48 |
| Non-Life – AGCS | 2025-Q4 | 2025-Q4 | 12M | 479.3 | – | – | 48 |
| Non-Life – Central Europe | 2025-Q4 | 2025-Q4 | 12M | 471.8 | – | – | 48 |
| Life – Other markets | 2025-Q4 | 2025-Q4 | 12M | 372.9 | – | – | 48 |
| Non-Life – United Kingdom | 2025-Q4 | 2025-Q4 | 12M | 369.8 | – | – | 48 |
| Non-Life – France | 2025-Q4 | 2025-Q4 | 12M | 318.2 | – | – | 48 |
| Life – Germany Health | 2025-Q4 | 2025-Q4 | 12M | 259.5 | – | – | 48 |
| Non-Life – Australia | 2025-Q4 | 2025-Q4 | 12M | 221.4 | – | – | 48 |
| Non-Life – Latin America | 2025-Q4 | 2025-Q4 | 12M | 181.9 | – | – | 48 |
| Non-Life – Other | 2025-Q4 | 2025-Q4 | 12M | 141.9 | – | – | 48 |
| Life – Germany APR | 2025-Q4 | 2025-Q4 | 12M | 66.7 | – | – | 48 |
| Life – Health insurance | FY2024 | 2025-Q4 | 12M | 730.5 | – | – | 48 |
| Property-Casualty Insurance Operations | 2024-H1 | 2026-H1 | 6M | 49,615 | 5.6% | 9.8% | 31 |
| Life/Health Insurance Operations | 2024-H1 | 2026-H1 | 6M | 44,772 | 1.6% | 6.5% | 31 |
| Life/Health | 2024-Q2 | 2026-Q1 | 3M | 22,600 | -9% | – | 33 |
| Life and Health Insurance | 2024-Q1 | 2026-Q1 | 3M | 22.6 | – | – | 34 |
| Motor | FY2023 | FY2025 | 12M | 8,392 | 16.2% | 98.8% | 28 |
| Fire and Property Reinsurance | FY2023 | FY2025 | 12M | 5,332 | -3.3% | 85.4% | 28 |
| Liability | FY2023 | FY2025 | 12M | 1,680 | 10.9% | 96.6% | 28 |
| Marine and Aviation | FY2023 | FY2025 | 12M | 559 | 2.6% | 88.1% | 28 |
| Personal Accident | FY2023 | FY2025 | 12M | 494 | 2.4% | 75.7% | 28 |
| Property and Casualty | 2023-Q3 | 2026-Q1 | 3M | 28.3 | 6% | – | 34 |
| Life and Health | 2023-Q3 | 2026-Q2 | 6M | – | -5% | 5% | 36 |
| Property-Casualty | FY2022 | 2026-H1 | 6M | 40,408 | – | – | 31 |
| Life/Health | FY2022 | 2026-H1 | 6M | 12,639 | – | – | 31 |
| German Speaking Countries, Central Europe | FY2024 | FY2024 | 12M | 320,179 | – | – | 15 |
| USA | FY2024 | FY2024 | 12M | 156,636 | – | – | 15 |
| Western & Southern Europe | FY2024 | FY2024 | 12M | 123,425 | – | – | 15 |
| Property-Casualty Insurance | FY2024 | FY2024 | 12M | 82,900 | 8.3% | – | 15 |
| Global Insurance Lines, Anglo Markets, Iberia, Latin America, Africa – Property-Casualty | FY2024 | FY2024 | 12M | 30,516 | – | – | 15 |
| Asia Pacific | FY2024 | FY2024 | 12M | 23,812 | – | – | 15 |
| German Speaking Countries, Central Europe – Property-Casualty | FY2024 | FY2024 | 12M | 19,192 | – | – | 15 |
| Property-Casualty reinsurance | FY2024 | FY2024 | 12M | 17,276 | – | – | 16 |
| German Speaking Countries, Central Europe – Life/Health | FY2024 | FY2024 | 12M | 11,271 | – | – | 15 |
| Motor reinsurance | FY2024 | FY2024 | 12M | 7,221 | 25.4% | 102.5% | 16 |
| Asia Pacific – Property-Casualty | FY2024 | FY2024 | 12M | 6,648 | – | – | 15 |
| Western & Southern Europe – Life/Health | FY2024 | FY2024 | 12M | 6,029 | – | – | 15 |
| Life/Health Life | FY2024 | FY2024 | 12M | 5,505.1 | – | – | 55 |
| Property-Casualty Non-Life | FY2024 | FY2024 | 12M | 4,908 | – | – | 55 |
| USA – Life/Health | FY2024 | FY2024 | 12M | 2,666 | – | – | 15 |
| Asia Pacific – Life/Health | FY2024 | FY2024 | 12M | 2,311 | – | – | 15 |
| Global Insurance Lines, Anglo Markets, Iberia, Latin America, Africa – Life/Health | FY2024 | FY2024 | 12M | 1,007 | – | – | 15 |
| Life/Health reinsurance | FY2024 | FY2024 | 12M | 610 | – | – | 16 |
| Property-Casualty Reinsurance Total | FY2023 | FY2023 | 12M | 13,765 | – | – | 8 |
| Household and Homeowner | FY2023 | FY2024 | 12M | 1,836 | 30.7% | 97.2% | 16 |
| Fire | FY2023 | FY2024 | 12M | 1,593 | 58.9% | 109.2% | 16 |
| Other Lines | FY2023 | FY2024 | 12M | 1,322 | 19.7% | 112% | 16 |
| Other Property Reinsurance | FY2023 | FY2024 | 12M | 1,202 | 5.3% | 103.1% | 16 |
| Life/Health Reinsurance Total | FY2023 | FY2023 | 12M | 949 | – | – | 8 |
| Engineering | FY2023 | FY2024 | 12M | 600 | 27.8% | 95.2% | 16 |
| Life | FY2023 | FY2024 | 12M | 565 | 15.7% | – | 16 |
| Non-Proportional Casualty Reinsurance | FY2023 | FY2023 | 12M | 396.1 | – | – | 63 |
| Credit and Bond | FY2023 | FY2024 | 12M | 364 | 9.6% | 85% | 16 |
| Legal Expenses | FY2023 | FY2024 | 12M | 313 | 1.7% | 88.9% | 16 |
| Business Interruption | FY2023 | FY2024 | 12M | 283 | 19.4% | 80.2% | 16 |
| Proportional miscellaneous financial loss reinsurance | FY2023 | FY2023 | 12M | 62.5 | – | – | 63 |
| Proportional general liability insurance | FY2023 | FY2023 | 12M | 55.1 | – | – | 63 |
| Health | FY2023 | FY2024 | 12M | 44 | 84.1% | – | 16 |
| Proportional credit and surety reinsurance | FY2023 | FY2023 | 12M | 40.4 | – | – | 63 |
| Proportional legal expenses reinsurance | FY2023 | FY2023 | 12M | 29.3 | – | – | 63 |
| Proportional marine, aviation and transport reinsurance | FY2023 | FY2023 | 12M | 19.3 | – | – | 63 |
| Non-proportional marine, aviation and transport reinsurance | FY2023 | FY2023 | 12M | 13.7 | – | – | 63 |
| Non-proportional health reinsurance | FY2023 | FY2023 | 12M | 8.8 | – | – | 63 |
| Proportional assistance reinsurance | FY2023 | FY2023 | 12M | 0.8 | – | – | 63 |
| Health reinsurance | FY2023 | FY2023 | 12M | -1.4 | – | – | 63 |
| Life reinsurance | FY2023 | FY2023 | 12M | -7.8 | – | – | 63 |
| Proportional other motor reinsurance | FY2023 | FY2023 | 12M | -149.1 | – | – | 63 |
| Non-proportional property reinsurance | FY2023 | FY2023 | 12M | -158.7 | – | – | 63 |
| Proportional motor liability insurance | FY2023 | FY2023 | 12M | -211.9 | – | – | 63 |
| Proportional fire and other property reinsurance | FY2023 | FY2023 | 12M | -442.3 | – | – | 63 |
| Corporate and Other | – | FY2023 | – | – | – | – | 7 |
Products & M&A (1/16 active+recent)#
Product announcements from the reports; market launches, approvals, partnerships; with first mention (date) and source. “Active/current” means: still mentioned in the most recent reports; what the company no longer mentions moves to the expandable part but is never deleted. Rows in grey are discontinued products.
| Product/Line | Since | Status | Source |
|---|---|---|---|
| Dividend payments from stake in Viridium (2x) | 2026-06 | Launched | 36 |
| Quantitative targets for Sustainable Solutions revenues incorporated into Board of Management remuneration scheme | 2024-01 | Launched | 15 |
| Generative AI and ChatGPT training for managers | 2023-10 | Launched | 7 |
| Global Risk Assessment (GloRiA) tool launch (climate risk awareness for customers) | 2023-06 | Launched | 8 |
| Sustainable Solutions framework launch (2x) | 2023-01 | Launched | 8 |
| Sustainable Solutions framework incorporated into binding Allianz Standard for P&C Underwriting | 2023-01 | Launched | 15 |
| Renewable energy insurance (solar and wind farms) (2x) | 2023 | Launched | 15 |
| Move Now program launch (global youth and disability employment initiative) | 2023 | Launched | 8 |
| Master Products creation (21 Property-Casualty templates) | 2023 | Launched | 8 |
| Higher interest rate environment | 2023 | Launched | 7 |
| Global Fit4IT day for employee upskilling | 2023 | Launched | 7 |
| EDGE recertification for gender equality | 2023 | Launched | 7 |
| Battery electric vehicle (BEV) insurance products | 2023 | Launched | 15 |
| Allianz Solvd claims service platform launch | 2023 | Launched | 8 |
| Allianz Free Share offering to employees | 2023 | Launched | 7 |
| Allianz Customer Model (ACM) rollout | 2023 | Launched | 8 |
M&A (42)#
All recorded acquisitions (purchases) and divestitures/exits with date, short description and source; deliberately including smaller transactions that summaries often miss. Purchase prices appear only where the company itself has disclosed them. Rows in grey are cancelled transactions; the cancellation date is shown in the row.
Acquisitions
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| UOB Asset Management (UOBAM) acquisition | 2027 | Completed | 31 |
| HSBC Life Singapore acquisition | 2027 | Completed | 31 |
| Acquisition of Eurofil insurance portfolio | 2026-01 | Completed | 31 |
| Cronos Vita portfolio assignment | 2025-10 | Completed | 28 |
| Viridium Group acquisition (3x) | 2025-08 | Completed | 28 |
| iptiQ EMEA P&C S.A. acquisition | 2025-07 | Completed | 28 |
| RAA partnership and acquisition | 2025-07 | Completed | 18 |
| RAA Insurance Holdings Limited acquisition | 2025-07 | Completed | 28 |
| JFSL Allianz reinsurance joint venture | 2025-07 | Completed | 18 |
| 20-year exclusive distribution agreement with Royal Automobile Association of South Australia for Home and Motor insurance | 2025-07 | Announced | 48 |
| Strategic realignment of joint ventures in India | 2025 | Completed | 28 |
| Share buyback program 2026 (2x) | 2025 | Completed | 28 |
| Participation in Viridium, leading European life insurance consolidation platform | 2025 | Completed | 28 |
| Issuance of Restricted Tier 1 bond | 2025 | Completed | 28 |
| €0.6 billion 3.375% undated subordinated bond redemption | 2024-09 | Completed | 10 |
| Income Insurance acquisition offer | 2024-07 | Completed | 10 |
| Share buy-back program (3×) | 2024-02 | Completed | 31 |
| Subordinated bond placement €1.0 bn and USD 1.25 bn | 2024 | Completed | 16 |
| Reinsurance agreement (Allianz Re) | 2024 | Completed | 11 |
| Subordinated bond redemption | 2024 | Completed | 56 |
| Subordinated bond issuance 2 (2×) | 2024 | Completed | 56 |
| Share buy-back program (5×) | 2024 | Completed | 12 |
| TUA Assicurazioni S.p.A. acquisition (3×) | 2023-11 | Completed | 15 |
| Reorganization of insurance activities structure | 2023-01 | Completed | 2 |
| Innovation Group Holdings Ltd. acquisition | 2023-01 | Completed | 7 |
| Bancassurance partnership in the Netherlands | 2023 | Completed | 8 |
| Formation of partnership with Sanlam Ltd. (3×) | 2022-05 | Completed | 7 |
Divestitures / exits
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| Sale of 26% share in BAGIC and BALIC to Bajaj Promotor Group | 2026-01 | Divested | 31 |
| Bajaj Allianz joint ventures 23% stake sale (4×) | 2026-01 | Divested | 48 |
| PIMCO M-unit Plan termination and buyout | 2026 | Divested | 31 |
| Cronos Vita Assicurazioni S.p.A. split and portfolio transfer | 2025-10 | Divested | 48 |
| UniCredit Allianz Vita stake sale (4×) | 2025-06 | Divested | 31 |
| Bajaj General Insurance and Bajaj Life Insurance stake sale (3×) | 2025-03 | Divested | 28 |
| Sale of stakes in Indian joint ventures (2x) | 2025 | Divested | 36 |
| Sale of UniCredit Allianz Vita S.p.A. (3x) | 2025 | Divested | 36 |
| AGCS U.S. mid-corp and entertainment portfolio transfer to Arch Insurance | 2024-08 | Divested | 10 |
| Sale of Euler Hermes Re S.A. (4x) | 2024-01 | Divested | 7 |
| Repayment of €1.5 bn subordinated bond | 2024 | Divested | 16 |
| Allianz Saudi Fransi stake sale to Abu Dhabi National Insurance Company | 2023-09 | Divested | 62 |
| Allianz Saudi Fransi stake sale (4x) | 2023-09 | Divested | 15 |
| Lebanese business operations sale to GGC SNA Holdings Limited (2x) | 2023-07 | Divested | 7 |
| Russian insurance operations sale to Interholding LLC (2x) | 2023-05 | Divested | 7 |
Reported KPIs (as disclosed) (973)#
Figures the company discloses itself in addition to the standard financials; order intake, recurring revenue, user or unit counts, adjusted measures. These “story KPIs” usually slip through standard databases; here they are collected as reported, with no calculation of our own. Important: the definition comes from the company itself and can differ from firm to firm; period and source are stated next to every value.
| Date | Period | KPI | Value / change | Source |
|---|---|---|---|---|
| 2026-08-07 | 2026-Q2 | Contractual service margin (CSM) | 57,3 Milliarden Euro | 36 |
| 2026-08-07 | 2026-Q2 | Solvency II ratio | 225% | 36 |
| 2026-08-07 | 2026-Q2 | Loss ratio | 68,1% | 36 |
| 2026-08-07 | 2026-Q2 | Combined ratio | 91,9% | 36 |
| 2026-08-07 | 2026-Q2 | Value of new business | 1,1 Milliarden Euro | 36 |
| 2026-08-07 | 2026-Q2 | New business margin | 5,6% | 36 |
| 2026-08-07 | 2026-Q2 | Net inflows into third-party assets under management | 39 Milliarden Euro | 36 |
| 2026-08-07 | 2026-Q2 | Expense ratio | 23,8% | 36 |
| 2026-08-07 | 2026-Q2 | Third-party assets under management | 2.161 Billionen Euro | 36 |
| 2026-08-07 | 2026-Q2 | Equity | 62,9 Milliarden Euro | 36 |
| 2026-08-07 | 2026-Q2 | Average third-party assets under management | 2.093 Billionen Euro | 36 |
| 2026-08-07 | 2026-Q2 | Present value of new business premiums (PVNBP) | 19,6 Milliarden Euro | 36 |
| 2026-08-07 | 2026-Q2 | Cost-income ratio | 60,2% | 36 |
| 2026-08-07 | 2026-Q2 | Annualised adjusted return on equity | 20,7% | 36 |
| 2026-08-05 | 2026-H1 | Value of new business (Life/Health) | 2,355 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Undated subordinated bonds | 5,343 | 31 |
| 2026-08-05 | 2026-H1 | Third-party assets under management | 2,161 (EUR € bn) | 31 |
| 2026-08-05 | 2026-H1 | Solvency II capitalization ratio | 225 | 31 |
| 2026-08-05 | 2026-H1 | Shareholders' equity | 62,865 | 31 |
| 2026-08-05 | 2026-H1 | Reinsurance contract assets | 28,138 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Non-controlling interests | 3,685 | 31 |
| 2026-08-05 | 2026-H1 | Loss ratio | 67.7 | 31 |
| 2026-08-05 | 2026-H1 | Issued capital | 1,170 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Investments | 790,606 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Investment contract liabilities | 53,319 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Insurance contract liabilities | 833,759 | 31 |
| 2026-08-05 | 2026-H1 | Insurance contract assets | 273 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Financial assets for unit linked contracts | 171,687 (EUR € mn) | 31 |
| 2026-08-05 | 2026-H1 | Expense ratio | 23.7 | 31 |
| 2026-08-05 | 2026-H1 | Cost-income ratio (Asset Management) | 60.3 | 31 |
| 2026-08-05 | 2026-H1 | Core return on equity (Life/Health) | 19.0 (EUR %) | 31 |
| 2026-08-05 | 2026-H1 | Core return on equity | 20.7 (EUR %) | 31 |
| 2026-08-05 | 2026-H1 | Combined ratio | 91.4 | 31 |
| 2026-08-05 | 2026-H1 | Additional paid-in capital | 27,732 (EUR € mn) | 31 |
| – | 2026-H1 | Contractual service margin (net) | 36,2 Mrd € | 35 |
| – | 2026-H1 | Solvency II capital ratio | 225% | 35 |
| – | 2026-H1 | Combined ratio | 91,4% | 35 |
| – | 2026-H1 | New business margin | 5,4% | 35 |
| – | 2026-H1 | Third-party assets under management | 2.161 Mrd € | 35 |
| – | 2026-H1 | Adjusted return on equity | 20,7% | 35 |
| – | 2026-H1 | Cost-income ratio | 60,3% | 35 |
| 2026-05-13 | 2026-Q1 | Contractual service margin | 55,4 Mrd € | 34 |
| 2026-05-13 | 2026-Q1 | Solvency II ratio | 221% | 34 |
| 2026-05-13 | 2026-Q1 | Loss ratio | 67,3% | 34 |
| 2026-05-13 | 2026-Q1 | Combined ratio | 91,0% | 34 |
| 2026-05-13 | 2026-Q1 | New business margin | 5,3% | 34 |
| 2026-05-13 | 2026-Q1 | Net flows into assets under management | 45,2 Mrd € | 34 |
| 2026-05-13 | 2026-Q1 | Expense ratio | 23,7% | 34 |
| 2026-05-13 | 2026-Q1 | Cost-income ratio | 60,4% | 34 |
| 2026-03-31 | 2026-Q1 | Contractual service margin (net) | 34,9 Mrd € | 33 |
| 2026-03-31 | 2026-Q1 | Solvency II capital ratio | 221% | 33 |
| 2026-03-31 | 2026-Q1 | Combined ratio | 91,0% | 33 |
| 2026-03-31 | 2026-Q1 | New business margin Life/Health | 5,3% | 33 |
| 2026-03-31 | 2026-Q1 | Equity | 65,9 Mrd € | 33 |
| 2026-03-31 | 2026-Q1 | Adjusted return on equity | 24,2% | 33 |
| 2026-03-31 | 2026-Q1 | Cost-income ratio Asset Management | 60,4% | 33 |
| 2026-03-12 | FY2025 | Treasury shares held | 176,699 | 29 |
| 2026-03-12 | FY2025 | Dividend per share | 17.10 | 29 |
| 2026-03-02 | FY2025 | plan participants | 128,000 | 28 |
| 2026-03-02 | FY2025 | core diluted earnings per share | 28.59 | 28 |
| 2026-03-02 | FY2025 | core basic earnings per share | 28.61 | 28 |
| 2026-03-02 | FY2025 | Valuation result | 3,266 | 28 |
| 2026-03-02 | FY2025 | Underwriting risk | 16,634 | 28 |
| 2026-03-02 | FY2025 | Total net investment income | 29,405 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Total investments | 753,487 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Total business volume growth 2025 | 8.1 % | 28 |
| 2026-03-02 | FY2025 | Total assets | 764.2 (EUR € bn) | 28 |
| 2026-03-02 | FY2025 | Sustainability basket target achievement | 142.33% | 28 |
| 2026-03-02 | FY2025 | Solvency II capitalization ratio 2024 | 209 | 28 |
| 2026-03-02 | FY2025 | Solvency II capitalization ratio | 218 | 28 |
| 2026-03-02 | FY2025 | Shareholders' equity | 62,722 | 28 |
| 2026-03-02 | FY2025 | Shareholders equity increase 2025 | 2.4 bn | 28 |
| 2026-03-02 | FY2025 | Share buyback 2025 | 2.0 bn | 28 |
| 2026-03-02 | FY2025 | Recordable work related accidents 2025 | 719 | 28 |
| 2026-03-02 | FY2025 | Realized gains/losses (net) | (918) | 28 |
| 2026-03-02 | FY2025 | Real estate held for investment | 21,178 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Real estate | 23.0 | 28 |
| 2026-03-02 | FY2025 | Rate of recordable work related accidents 2025 | 3.1 | 28 |
| 2026-03-02 | FY2025 | Property Casualty loss ratio without nat cat IFRS17 | 66.9 | 28 |
| 2026-03-02 | FY2025 | Property Casualty loss ratio IFRS17 | 68.3 | 28 |
| 2026-03-02 | FY2025 | Property Casualty combined ratio 2025 | 92.2 % | 28 |
| 2026-03-02 | FY2025 | Operational risk | 4,103 | 28 |
| 2026-03-02 | FY2025 | Operating profit target achievement | 134.36% | 28 |
| 2026-03-02 | FY2025 | Operating profit 2025 | 17.4 bn | 28 |
| 2026-03-02 | FY2025 | Net retention ratio | 92.3 | 28 |
| 2026-03-02 | FY2025 | Net income target achievement | 129.16% | 28 |
| 2026-03-02 | FY2025 | Money market securities 2025 | 1,166 | 28 |
| 2026-03-02 | FY2025 | Money market securities 2024 | 1,420 | 28 |
| 2026-03-02 | FY2025 | Market risk | 22,699 | 28 |
| 2026-03-02 | FY2025 | Loans | 70,066 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Life Health normalized CSM growth 2025 | 5.2 % | 28 |
| 2026-03-02 | FY2025 | Life Health CSM release rate 2025 | 8.9 % | 28 |
| 2026-03-02 | FY2025 | Investment expenses | (1,956) | 28 |
| 2026-03-02 | FY2025 | Interest result | 29,014 | 28 |
| 2026-03-02 | FY2025 | Insurance Revenue | 102,802 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Inclusive Meritocracy Index 2025 | 84 % | 28 |
| 2026-03-02 | FY2025 | Inclusive Meritocracy Index | 143.75% | 28 |
| 2026-03-02 | FY2025 | Group targets overall achievement | 133.87% | 28 |
| 2026-03-02 | FY2025 | Government bonds | 189.1 | 28 |
| 2026-03-02 | FY2025 | Government bonds | 181,834 | 28 |
| 2026-03-02 | FY2025 | Funds | 81.6 | 28 |
| 2026-03-02 | FY2025 | Financial liabilities measured at fair value | 20,117 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Financed GHG emissions 2025 | 10.1 mn t CO2e | 28 |
| 2026-03-02 | FY2025 | Equity investments | 29,690 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Equities | 50.5 | 28 |
| 2026-03-02 | FY2025 | Employees covered by health safety management 2025 | 99.4 % | 28 |
| 2026-03-02 | FY2025 | Emission reduction own investments | 143.23% | 28 |
| 2026-03-02 | FY2025 | Dividend per share 2025 | 17.10 | 28 |
| 2026-03-02 | FY2025 | Dividend payout 2025 | 5.9 bn | 28 |
| 2026-03-02 | FY2025 | Digital Net Promoter Score 2025 | 70 % | 28 |
| 2026-03-02 | FY2025 | Digital Net Promoter Score | 140.00% | 28 |
| 2026-03-02 | FY2025 | Derivatives | 23,761 | 28 |
| 2026-03-02 | FY2025 | Debt investments measured at fair value | 539,260 (EUR € mn) | 28 |
| 2026-03-02 | FY2025 | Credit risk | 4,249 | 28 |
| 2026-03-02 | FY2025 | Covered bonds | 44.0 | 28 |
| 2026-03-02 | FY2025 | Covered bonds | 42,601 | 28 |
| 2026-03-02 | FY2025 | Corporate bonds | 208.5 | 28 |
| 2026-03-02 | FY2025 | Corporate bonds | 202,127 | 28 |
| 2026-03-02 | FY2025 | Core return on equity 2025 | 18.1 % | 28 |
| 2026-03-02 | FY2025 | Combined ratio Motor | 98.8 | 28 |
| 2026-03-02 | FY2025 | Combined ratio Liability | 96.6 | 28 |
| 2026-03-02 | FY2025 | Combined ratio Fire and property | 85.4 | 28 |
| 2026-03-02 | FY2025 | Capital requirement | 43.3 bn | 28 |
| 2026-03-02 | FY2025 | CSM as of 31 December | 55,897 | 28 |
| 2026-03-02 | FY2025 | CSM as of 1 January | 56,065 | 28 |
| 2026-03-02 | FY2025 | Business risk | 8,018 | 28 |
| 2026-03-02 | FY2025 | Asset Management cost income ratio 2025 | 60.7 % | 28 |
| 2026-03-02 | FY2025 | ABS/MBS | 27,684 | 28 |
| 2025-12-11 | FY2025 | Volatility adjustment non-life insurance | 150 598 Tsd € | 49 |
| 2025-12-11 | FY2025 | Volatility adjustment life health insurance | 4 605 Tsd € | 49 |
| 2025-12-11 | FY2025 | Ratio of eligible own funds to SCR | 266% | 49 |
| 2025-12-11 | FY2025 | Ratio of eligible own funds to MCR | 949% | 49 |
| 2025-12-11 | FY2025 | Solvency capital requirement | 35 559 744 | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario combined market event | 259 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario interest rate risk | 266 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario currency risk | 261 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario premium risk | 263 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario natural catastrophes | 265 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario financial crisis 2008 | 258 % | 49 |
| 2025-12-11 | FY2025 | Solvency II ratio scenario equity risk | 260 % | 49 |
| 2025-12-11 | FY2025 | Solvency II capital ratio | 266 % | 49 |
| 2025-12-11 | FY2025 | Solvency II Capital Ratio | 266 % | 49 |
| 2025-12-11 | FY2025 | Subordinated liabilities | 16 441 959 | 49 |
| 2025-12-11 | FY2025 | Minimum capital requirement | 8 889 936 | 49 |
| 2025-12-11 | FY2025 | Credit risk scenario LGD | 10,5 % | 49 |
| 2025-12-11 | FY2025 | Credit risk scenario downgrade | 25,8 % | 49 |
| 2025-12-11 | FY2025 | Share capital | 1 169 920 | 49 |
| 2025-12-11 | FY2025 | Total eligible basic own funds after deductions | 94 731 578 | 49 |
| 2025-12-11 | FY2025 | Share premium on share capital | 28 060 486 | 49 |
| 2025-12-11 | FY2025 | Eligible own funds | 94 731 578 | 49 |
| – | FY2025 | VNB | 1,217 | 45 |
| – | FY2025 | Tax rate | 26 | 45 |
| – | FY2025 | Solvency II capitalization ratio (regulatory view) | 218 | 30 |
| – | FY2025 | SII ratio | 218 | 45 |
| – | FY2025 | Run-off | -2.6 | 45 |
| – | FY2025 | Normalized CSM growth | 5.23 | 30 |
| – | FY2025 | Net flows | 45 | 45 |
| – | FY2025 | NatCat | 1.9 | 45 |
| – | FY2025 | NBM | 5.8 | 45 |
| – | FY2025 | Loss ratio | 68.3 | 30 |
| – | FY2025 | Expense ratio | 23.9 | 30 |
| – | FY2025 | ER | 23.8 | 45 |
| – | FY2025 | Discounting impact | -2.3 | 45 |
| – | FY2025 | DPS | 17.10 | 45 |
| – | FY2025 | Cost-income ratio | 60.7 | 30 |
| – | FY2025 | Core return on equity | 18.1 (EUR %) | 30 |
| – | FY2025 | Combined ratio | 92.2 | 30 |
| – | FY2025 | CoR | 93.6 | 45 |
| – | FY2025 | CIR | 60.0 | 45 |
| – | FY2025 | 3rd party AuM | 1,990 | 45 |
| 2026-02-26 | 2025-Q4 | Solvency II ratio | 218% | 46 |
| 2026-02-26 | 2025-Q4 | Loss ratio property casualty | 68.3% | 46 |
| 2026-02-26 | 2025-Q4 | Combined ratio property casualty | 92.2% | 46 |
| 2026-02-26 | 2025-Q4 | Assets under management | 2,512 (EUR EUR bn) | 46 |
| 2026-02-26 | 2025-Q4 | Contractual service margin (net) | 35,4 | 27 |
| 2026-02-26 | 2025-Q4 | Solvency II ratio | 218 | 27 |
| 2026-02-26 | 2025-Q4 | Combined ratio | 92,2 | 27 |
| 2026-02-26 | 2025-Q4 | New business margin | 5,7 | 27 |
| 2026-02-26 | 2025-Q4 | Third-party assets under management | 1.990 | 27 |
| 2026-02-26 | 2025-Q4 | Equity | 62,7 | 27 |
| 2026-02-26 | 2025-Q4 | Adjusted return on equity | 18,1 | 27 |
| 2026-02-26 | 2025-Q4 | Cost-income ratio | 60,7 | 27 |
| – | 2025-Q4 | Total liabilities MVBS | 705,551,247 | 48 |
| – | 2025-Q4 | Total assets MVBS | 791,729,838 (EUR € thou) | 48 |
| – | 2025-Q4 | Solvency ratio | 2.18 | 48 |
| – | 2025-Q4 | Solvency II capitalization ratio | 218% | 48 |
| – | 2025-Q4 | Solvency II capitalization | 218% | 48 |
| – | 2025-Q4 | Solvency capital requirement | 43,259,437 (EUR in thousands) | 48 |
| – | 2025-Q4 | Severance payment cap | 2 x target remuneration | 48 |
| – | 2025-Q4 | Relative TSR performance factor minimum | 0% | 48 |
| – | 2025-Q4 | Relative TSR performance factor maximum | 200% | 48 |
| – | 2025-Q4 | Operating revenues asset management | 8,506,709 (EUR in thousands) | 48 |
| – | 2025-Q4 | Operating result corporate and other | (564,612) | 48 |
| – | 2025-Q4 | operating profit asset management | 3,345,034 (EUR in thousands) | 48 |
| – | 2025-Q4 | minimum consolidated group SCR | 25,685,983 | 48 |
| – | 2025-Q4 | LTI payout cap | 200% | 48 |
| – | 2025-Q4 | group SCR | 43,259,437 | 48 |
| – | 2025-Q4 | financial conglomerate capitalization ratio | 218% | 48 |
| – | 2025-Q4 | excess of assets over liabilities | 86,178,591 (EUR € thou) | 48 |
| – | 2025-Q4 | eligible own funds | 94,509,292 | 48 |
| – | 2025-Q4 | customers served | 97 million | 48 |
| – | 2025-Q4 | combined ratio non-life | 92.2% | 48 |
| – | 2025-Q4 | board remuneration cap regular member | € 7,168,455 | 48 |
| – | 2025-Q4 | board remuneration cap chairperson | € 14,050,171.80 | 48 |
| – | 2025-Q4 | annual bonus target achievement maximum | 150% | 48 |
| – | 2025-Q4 | ABS/MBS percentage of debt instruments | 6% | 48 |
| – | 2025-Q4 | ABS/MBS exposure | 32,831,366 | 48 |
| – | 2025-Q4 | ABS investment grade rating | 96% | 48 |
| – | 2025-Q4 | ABS AA or better rating | 62% | 48 |
| – | 2025-Q4 | Contractual service margin (net) | 35,4 | 26 |
| – | 2025-Q4 | Third-party assets under management | 1,990 (EUR millions) | 47 |
| – | 2025-Q4 | Solvency II capitalization ratio | 218% | 47 |
| – | 2025-Q4 | rate of medical cost trend | 5.3 | 48 |
| – | 2025-Q4 | rate of compensation increase | 2.8 | 48 |
| – | 2025-Q4 | property-casualty combined ratio | 93.6% | 47 |
| – | 2025-Q4 | life/health new business margin | 5.8% | 47 |
| – | 2025-Q4 | Equity ratio | 62,7 | 26 |
| – | 2025-Q4 | Discount rate short duration | 3.7 | 48 |
| – | 2025-Q4 | Discount rate long duration | 4.3 | 48 |
| – | 2025-Q4 | Discount rate United Kingdom | 5.5 | 48 |
| – | 2025-Q4 | Discount rate Switzerland | 1.3 | 48 |
| – | 2025-Q4 | Discount rate Germany | 4.1 | 48 |
| – | 2025-Q4 | Core return on equity | 18.1% | 47 |
| – | 2025-Q4 | Contractual service margin (net) | 35.4 | 47 |
| – | 2025-Q4 | Adjusted return on equity | 18,1% | 26 |
| – | 2025-Q4 | Asset Management cost-income ratio | 60.0% | 47 |
| 2025-11-14 | 2025-Q3 | Contractual service margin | 55,5 | 25 |
| 2025-11-14 | 2025-Q3 | Solvency II capitalisation ratio | 209% | 25 |
| 2025-11-14 | 2025-Q3 | Loss ratio | 68,3% | 25 |
| 2025-11-14 | 2025-Q3 | Combined ratio | 91,9% | 25 |
| 2025-11-14 | 2025-Q3 | New business margin | 5,9% | 25 |
| 2025-11-14 | 2025-Q3 | Net inflows into third-party assets under management | 51 | 25 |
| 2025-11-14 | 2025-Q3 | Expense ratio | 23,6% | 25 |
| 2025-11-14 | 2025-Q3 | Adjusted return on equity | 18,5% | 25 |
| 2025-11-14 | 2025-Q3 | Cost-income ratio | 60,3% | 25 |
| 2025-11-13 | 2025-Q3 | Total business volume 2024 | 179.8 billion euros | 19 |
| 2025-11-13 | 2025-Q3 | Third party assets under management | 1.8 trillion euros | 19 |
| 2025-11-13 | 2025-Q3 | Operating profit 2024 | 16.0 billion euros | 19 |
| 2025-11-13 | 2025-Q3 | Assets under management insurance | 749 billion euros | 19 |
| 2025-08-07 | 2025-Q2 | Contractual service margin | 55,8 | 23 |
| 2025-08-07 | 2025-Q2 | Solvency II capitalisation ratio | 209% | 23 |
| 2025-08-07 | 2025-Q2 | Loss ratio | 67,4% | 23 |
| 2025-08-07 | 2025-Q2 | Combined ratio | 91,2% | 23 |
| 2025-08-07 | 2025-Q2 | Value of new business | 1.122 | 23 |
| 2025-08-07 | 2025-Q2 | New business margin | 5,7% | 23 |
| 2025-08-07 | 2025-Q2 | Net new money | 14 | 23 |
| 2025-08-07 | 2025-Q2 | Expense ratio | 23,9% | 23 |
| 2025-08-07 | 2025-Q2 | Third-party assets under management | 1.842 | 23 |
| 2025-08-07 | 2025-Q2 | Equity | 57,2 | 23 |
| 2025-08-07 | 2025-Q2 | Cost-income ratio | 61,3% | 23 |
| 2025-08-07 | 2025-Q2 | Annualised adjusted return on equity | 18,5% | 23 |
| 2025-08-05 | 2025-H1 | Weighted-average number of shares outstanding - diluted | 385,164,387 | 18 |
| 2025-08-05 | 2025-H1 | Weighted-average number of shares outstanding - basic | 385,022,257 | 18 |
| 2025-08-05 | 2025-H1 | Total equity | 60,512 (EUR in millions) | 18 |
| 2025-08-05 | 2025-H1 | Total business volume | 98,473 | 18 |
| 2025-08-05 | 2025-H1 | Total assets under management | 2,360 (EUR € bn) | 18 |
| 2025-08-05 | 2025-H1 | Total assets | 992,884 (EUR in millions) | 18 |
| 2025-08-05 | 2025-H1 | Third party assets under management | 1,842 (EUR € bn) | 18 |
| 2025-08-05 | 2025-H1 | Solvency II capitalization ratio | 209 | 18 |
| 2025-08-05 | 2025-H1 | Shareholders core net income | 5,527 | 18 |
| 2025-08-05 | 2025-H1 | Reinsurance contract assets | 26,059 (EUR in millions) | 18 |
| 2025-08-05 | 2025-H1 | Investment contract liabilities | 46,328 (EUR in millions) | 18 |
| 2025-08-05 | 2025-H1 | Insurance contract liabilities | 780,496 | 18 |
| 2025-08-05 | 2025-H1 | Dividend per qualifying share | 15.40 | 18 |
| 2025-08-05 | 2025-H1 | Core return on equity | 18.5 (EUR %-p) | 18 |
| 2025-08-05 | 2025-H1 | Core earnings per share | 13.99 | 18 |
| 2025-08-05 | 2025-H1 | Core diluted earnings per share | 13.98 | 18 |
| 2025-08-05 | 2025-H1 | Core diluted earnings per share | 13.98 | 18 |
| 2025-08-05 | 2025-H1 | Core basic earnings per share | 13.99 | 18 |
| 2025-08-05 | 2025-H1 | Contractual service margin | 55,775 | 18 |
| – | 2025-H1 | Solvency II capitalization ratio (regulatory) | 203% | 50 |
| – | 2025-H1 | Solvency II capitalization ratio (economic) | 209% | 50 |
| – | 2025-H1 | Normalized CSM growth | 2.83 | 50 |
| – | 2025-H1 | Loss ratio | 67.5 | 50 |
| – | 2025-H1 | Expense ratio | 24.0 | 50 |
| – | 2025-H1 | Cost-income ratio | 61.3 | 50 |
| – | 2025-H1 | Core return on equity (Life/Health) | 17.6 (EUR %) | 50 |
| – | 2025-H1 | Core return on equity (Allianz Group) | 18.5 (EUR %) | 50 |
| – | 2025-H1 | Combined ratio | 91.5 | 50 |
| 2025-05-15 | 2025-Q1 | Contractual service margin | 57,0 Milliarden Euro | 21 |
| 2025-05-15 | 2025-Q1 | Solvency II capitalisation ratio | 208 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Loss ratio | 67,7 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Combined ratio | 91,8 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Value of new business | 1.440 Millionen Euro | 21 |
| 2025-05-15 | 2025-Q1 | New business margin | 5,5 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Expense ratio | 24,1 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Third-party assets under management | 1.914 Billionen Euro | 21 |
| 2025-05-15 | 2025-Q1 | Equity | 62,4 Milliarden Euro | 21 |
| 2025-05-15 | 2025-Q1 | Cost-income ratio | 61,3 Prozent | 21 |
| 2025-05-15 | 2025-Q1 | Annualised adjusted return on equity | 16,6 Prozent | 21 |
| 2026-07-23 | FY2024 | Western Europe share of global growth, 20 years | 14.1% | 38 |
| 2026-07-23 | FY2024 | Western Europe share of financial assets 2024 | 11.1% | 38 |
| 2026-07-23 | FY2024 | Western Europe securities share of new savings | 26% | 38 |
| 2026-07-23 | FY2024 | Western Europe securities share | 34.9% | 38 |
| 2026-07-23 | FY2024 | Western Europe real estate growth 2024 | +1.2% | 38 |
| 2026-07-23 | FY2024 | Western Europe growth share 2024 | +4.6% | 38 |
| 2026-07-23 | FY2024 | Western Europe debt ratio change | -2.5 pps | 38 |
| 2026-07-23 | FY2024 | Western Europe debt growth 2024 | +1.5% | 38 |
| 2026-07-23 | FY2024 | Western Europe asset growth, 10 years | +3.8% | 38 |
| 2026-07-23 | FY2024 | US value increases contribution | 67% | 38 |
| 2026-07-23 | FY2024 | US top 10% wealth share | 67.2% | 38 |
| 2026-07-23 | FY2024 | US stock market growth 2024 | +23.3% | 38 |
| 2026-07-23 | FY2024 | US share of global growth 2024 | 53.6% | 38 |
| 2026-07-23 | FY2024 | US fresh savings pct | 2.0% | 38 |
| 2026-07-23 | FY2024 | Top 10% wealth share national average | 60.4% | 38 |
| 2026-07-23 | FY2024 | Top 10% wealth share global | 85.1% | 38 |
| 2026-07-23 | FY2024 | Share purchases 2024 | EUR818 bn | 38 |
| 2026-07-23 | FY2024 | Securities share of portfolios 2024 | 45.1% | 38 |
| 2026-07-23 | FY2024 | Securities growth 2024 | +12.0% | 38 |
| 2026-07-23 | FY2024 | Savings 2024 total | EUR4.2 trn | 38 |
| 2026-07-23 | FY2024 | Real estate value countries analyzed | EUR158 trn | 38 |
| 2026-07-23 | FY2024 | Real estate per capita US | EUR195,200 | 38 |
| 2026-07-23 | FY2024 | Real estate per capita Switzerland | EUR330,800 | 38 |
| 2026-07-23 | FY2024 | Real estate per capita Australia | EUR273,440 | 38 |
| 2026-07-23 | FY2024 | Real estate growth 2024 | +3.6% | 38 |
| 2026-07-23 | FY2024 | Real estate growth 2023 | +1.7% | 38 |
| 2026-07-23 | FY2024 | Ratio advanced to emerging markets | 18 | 38 |
| 2026-07-23 | FY2024 | Private debt growth 2024 | +3.1% | 38 |
| 2026-07-23 | FY2024 | North America share of financial assets 2024 | 51.7% | 38 |
| 2026-07-23 | FY2024 | North America securities share of new savings | 67% | 38 |
| 2026-07-23 | FY2024 | North America securities share | 59.2% | 38 |
| 2026-07-23 | FY2024 | North America savings share 2024 | EUR2.3 trn | 38 |
| 2026-07-23 | FY2024 | North America real estate growth 2024 | +5.1% | 38 |
| 2026-07-23 | FY2024 | North America financial assets growth 2024 | +9.4% | 38 |
| 2026-07-23 | FY2024 | North America debt ratio change | -15.9 pps | 38 |
| 2026-07-23 | FY2024 | North America debt growth 2024 | +2.0% | 38 |
| 2026-07-23 | FY2024 | North America asset growth 10 years | +6.2% | 38 |
| 2026-07-23 | FY2024 | Netherlands top 10 pct wealth share | 46.2% | 38 |
| 2026-07-23 | FY2024 | Net financial assets per capita global | EUR37,050 | 38 |
| 2026-07-23 | FY2024 | Net financial assets growth 2024 | +10.3% | 38 |
| 2026-07-23 | FY2024 | Median to average ratio national | 3.08 | 38 |
| 2026-07-23 | FY2024 | Median to average ratio global | 15 | 38 |
| 2026-07-23 | FY2024 | Median net financial assets global | EUR2,510 | 38 |
| 2026-07-23 | FY2024 | Japan share financial assets 2024 | 3.8% | 38 |
| 2026-07-23 | FY2024 | Japan real estate growth 2024 | +2.8% | 38 |
| 2026-07-23 | FY2024 | Japan growth share 2024 | +4.0% | 38 |
| 2026-07-23 | FY2024 | Japan debt ratio change | -6.1 pps | 38 |
| 2026-07-23 | FY2024 | Japan debt growth 2024 | +2.9% | 38 |
| 2026-07-23 | FY2024 | Investment funds inflows 2024 | EUR1.1 trn | 38 |
| 2026-07-23 | FY2024 | Global wealth middle class members | 890 mn | 38 |
| 2026-07-23 | FY2024 | Global low wealth class members | 4.3 bn | 38 |
| 2026-07-23 | FY2024 | Global High Wealth Class Members | 550 mn | 38 |
| 2026-07-23 | FY2024 | Global Financial Assets per Capita | EUR37,050 | 38 |
| 2026-07-23 | FY2024 | Global Financial Assets Growth 2024 | +8.7% | 38 |
| 2026-07-23 | FY2024 | Global Financial Assets Growth 2023 | +8.0% | 38 |
| 2026-07-23 | FY2024 | Global Debt Ratio | 62.6% | 38 |
| 2026-07-23 | FY2024 | Germany Value Increases Contribution | 32% | 38 |
| 2026-07-23 | FY2024 | Germany Top 10% Wealth Share | 60.4% | 38 |
| 2026-07-23 | FY2024 | Germany Fresh Savings % | 3.7% | 38 |
| 2026-07-23 | FY2024 | Germany Asset Growth 10 Years | +5.9% | 38 |
| 2026-07-23 | FY2024 | France Top 10% Wealth Share | 54.7% | 38 |
| 2026-07-23 | FY2024 | Eurozone Bank Deposits | EUR10.8 trn | 38 |
| 2026-07-23 | FY2024 | Eastern Europe Real Estate Growth 2024 | +10.6% | 38 |
| 2026-07-23 | FY2024 | DAX Growth 2024 | +18.8% | 38 |
| 2026-07-23 | FY2024 | China Top 10% Wealth Share | 67.9% | 38 |
| 2026-07-23 | FY2024 | China Top 10% Wealth Increase | +17.3 pps | 38 |
| 2026-07-23 | FY2024 | China Share Global Growth 20 Years | 19.8% | 38 |
| 2026-07-23 | FY2024 | China Share Financial Assets 2024 | 14.6% | 38 |
| 2026-07-23 | FY2024 | China Private Debt Growth 2024 | +3.4% | 38 |
| 2026-07-23 | FY2024 | China Private Debt Growth 20-Year Avg | +20% | 38 |
| 2026-07-23 | FY2024 | China Debt Ratio Change | +43.4 pps | 38 |
| 2026-07-23 | FY2024 | china debt ratio 2024 | 61.4% | 38 |
| 2026-07-23 | FY2024 | bank deposits share portfolios 2024 | 26.7% | 38 |
| 2026-07-23 | FY2024 | bank deposits growth 2024 | +5.7% | 38 |
| 2026-07-23 | FY2024 | australia nz real estate growth 2024 | +5.7% | 38 |
| 2025-03-03 | FY2024 | ultimate loss total | 429,564 | 15 |
| 2025-03-03 | FY2024 | total return during year | 28.7 % | 15 |
| 2025-03-03 | FY2024 | total investments | 752,815 (EUR in millions) | 15 |
| 2025-03-03 | FY2024 | third party net inflows | 84.8 bn | 15 |
| 2025-03-03 | FY2024 | third party assets growth | 12.1 % | 15 |
| 2025-03-03 | FY2024 | shareholders equity prior year | 41,437 | 16 |
| 2025-03-03 | FY2024 | shareholders equity | 43,167 | 16 |
| 2025-03-03 | FY2024 | shareholders core net income growth | 10.1 % | 15 |
| 2025-03-03 | FY2024 | share price year end | 295.90 | 15 |
| 2025-03-03 | FY2024 | return on equity | 16.9 % | 15 |
| 2025-03-03 | FY2024 | pvnbp growth | 21.6 % | 15 |
| 2025-03-03 | FY2024 | pc operating profit growth | 14.3 % | 15 |
| 2025-03-03 | FY2024 | pc business volume growth | 8.3 % | 15 |
| 2025-03-03 | FY2024 | new business margin | 5.7 % | 15 |
| 2025-03-03 | FY2024 | net retention ratio prior year | 90.4% | 16 |
| 2025-03-03 | FY2024 | net retention ratio | 93.9% | 16 |
| 2025-03-03 | FY2024 | net promoter score | 72 % | 15 |
| 2025-03-03 | FY2024 | net liability for incurred claims | 72,224 | 15 |
| 2025-03-03 | FY2024 | loss reserves total | 80,270 | 15 |
| 2025-03-03 | FY2024 | fair value underlying items | 531,082 (EUR in millions) | 15 |
| 2025-03-03 | FY2024 | expense ratio net property casualty reinsurance prior year | 29.3% | 16 |
| 2025-03-03 | FY2024 | expense ratio net property casualty reinsurance | 28.8% | 16 |
| 2025-03-03 | FY2024 | core EPS growth | 12.4 % | 15 |
| 2025-03-03 | FY2024 | combined ratio property casualty reinsurance prior year | 101.9% | 16 |
| 2025-03-03 | FY2024 | combined ratio property casualty reinsurance | 101.2% | 16 |
| 2025-03-03 | FY2024 | calendar year claims ratio net property casualty reinsurance prior year | 72.5% | 16 |
| 2025-03-03 | FY2024 | calendar year claims ratio net property casualty reinsurance | 72.4% | 16 |
| 2025-03-03 | FY2024 | brand value | 23.5 billion | 15 |
| 2025-03-03 | FY2024 | accident year claims ratio net property casualty reinsurance prior year | 76.9% | 16 |
| 2025-03-03 | FY2024 | accident year claims ratio net property casualty reinsurance | 74.2% | 16 |
| 2025-03-03 | FY2024 | WWI plus score 2024 | 79 | 15 |
| 2025-03-03 | FY2024 | WWI plus score 2023 | 76 | 15 |
| 2025-03-03 | FY2024 | unrealized gains losses insurance contracts net | 31,377 | 15 |
| 2025-03-03 | FY2024 | underwriting risk pre diversified | 4,729 | 16 |
| 2025-03-03 | FY2024 | Undated subordinated bonds | 4,915 | 15 |
| 2025-03-03 | FY2024 | total taxonomy underwriting | 85,826.3 | 15 |
| 2025-03-03 | FY2024 | total revenues | € 179.8 bn | 15 |
| 2025-03-03 | FY2024 | Total external leavers 2024 | 21,119 | 15 |
| 2025-03-03 | FY2024 | Total equity | 64,076 (EUR € mn) | 15 |
| 2025-03-03 | FY2024 | Total business volume | 179,778 | 15 |
| 2025-03-03 | FY2024 | Total active corporate engagements | 1,387 | 15 |
| 2025-03-03 | FY2024 | Taxonomy stemming from reinsurance activities proportion | 0.1 | 15 |
| 2025-03-03 | FY2024 | Taxonomy stemming from reinsurance activities | 59.7 | 15 |
| 2025-03-03 | FY2024 | Taxonomy reinsured retrocession | 3.3 | 15 |
| 2025-03-03 | FY2024 | Taxonomy reinsured premiums proportion | 0.2 | 15 |
| 2025-03-03 | FY2024 | Taxonomy reinsured premiums | 144.4 | 15 |
| 2025-03-03 | FY2024 | Taxonomy non-eligible proportion 2024 | 22.3 | 15 |
| 2025-03-03 | FY2024 | Taxonomy non-eligible proportion 2023 | 22.8 | 15 |
| 2025-03-03 | FY2024 | Taxonomy non-eligible activities | 19,139.9 | 15 |
| 2025-03-03 | FY2024 | Taxonomy eligible but not aligned proportion 2024 | 76.6 | 15 |
| 2025-03-03 | FY2024 | Taxonomy eligible but not aligned proportion 2023 | 76.3 | 15 |
| 2025-03-03 | FY2024 | Taxonomy eligible but not aligned premiums | 65,719.0 | 15 |
| 2025-03-03 | FY2024 | Taxonomy aligned premiums proportion 2024 | 1.1 | 15 |
| 2025-03-03 | FY2024 | Taxonomy aligned premiums proportion 2023 | 0.9 | 15 |
| 2025-03-03 | FY2024 | Taxonomy aligned premiums absolute | 967.5 | 15 |
| 2025-03-03 | FY2024 | Tax Adjustment | (266) | 16 |
| 2025-03-03 | FY2024 | Supervisory Board percentile - Regular members target compensation (DAX peers) | 87th percentile | 16 |
| 2025-03-03 | FY2024 | Supervisory Board percentile - Regular members maximum compensation | 75th percentile | 16 |
| 2025-03-03 | FY2024 | Supervisory Board percentile - Chairperson target compensation (DAX peers) | 86th percentile | 16 |
| 2025-03-03 | FY2024 | Supervisory Board percentile - Chairperson maximum compensation | 86th percentile | 16 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Stephanie Bruce since 05/2024) | 137.3 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Sophie Boissard) | 253.9 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Rashmy Chatterjee) | 206.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Prof. Dr. Nadine Brandl since 08/2024) | 72.9 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Primiano Di Paolo) | 181.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Michael Diekmann) | 758.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Martina Grundler until 02/2024) | 38.5 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Katharina Wesenick from 03/2024 until 06/2024) | 58.3 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Jürgen Lawrenz) | 206.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Jean-Claude Le Goaër) | 259.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Herbert Hainer until 05/2024) | 116.6 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Gabriele Burkhardt-Berg) | 306.0 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Frank Kirsch) | 250.7 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Dr. Jörg Schneider from 05/2024) | 248.7 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Dr. Friedrich Eichiner) | 373.6 | 15 |
| 2025-03-03 | FY2024 | Supervisory Board compensation (Christine Bosse until 05/2024) | 101.0 | 15 |
| 2025-03-03 | FY2024 | Subordinated liabilities | 18.7 bn | 16 |
| 2025-03-03 | FY2024 | Solvency II capitalization ratio | 209 | 15 |
| 2025-03-03 | FY2024 | Solvency II capitalization ratio | 209 % | 15 |
| 2025-03-03 | FY2024 | Solvency II Own Funds | 90.7 | 16 |
| 2025-03-03 | FY2024 | Solvency II Capitalization Ratio | 277 | 16 |
| 2025-03-03 | FY2024 | Solvency II Capital Requirement | 32.8 (EUR € bn) | 16 |
| 2025-03-03 | FY2024 | Shares in affiliated enterprises | 75.8 | 16 |
| 2025-03-03 | FY2024 | Shareholders' equity | 60,287 | 15 |
| 2025-03-03 | FY2024 | Shareholders equity | 60,287 | 15 |
| 2025-03-03 | FY2024 | Shareholders core net income | 10,017 | 15 |
| 2025-03-03 | FY2024 | Share buy-backs | € 1.5 bn | 15 |
| 2025-03-03 | FY2024 | Run-off result in Property-Casualty reinsurance | 273 mn | 16 |
| 2025-03-03 | FY2024 | Retained earnings | 33,316 | 15 |
| 2025-03-03 | FY2024 | Reserve Risk | 1,915 | 16 |
| 2025-03-03 | FY2024 | Premium Non Catastrophe Terror Risk | 2,215 | 16 |
| 2025-03-03 | FY2024 | Premium Natural Catastrophe Risk | 514 | 16 |
| 2025-03-03 | FY2024 | Other unrealized gains losses net | (36,610) | 15 |
| 2025-03-03 | FY2024 | Operational Risk Pre Diversified | 697 | 16 |
| 2025-03-03 | FY2024 | Non controlling interests | 3,789 | 15 |
| 2025-03-03 | FY2024 | Money market securities | 1,420 | 15 |
| 2025-03-03 | FY2024 | Market Risk Pre Diversified | 31,594 | 16 |
| 2025-03-03 | FY2024 | Lead or support multilateral engagements with climate focus 2024 | 15 | 15 |
| 2025-03-03 | FY2024 | Lead or support multilateral engagements 2024 | 15 | 15 |
| 2025-03-03 | FY2024 | Issued capital | 1,170 (EUR € mn) | 15 |
| 2025-03-03 | FY2024 | Investments in affiliated enterprises and participations | 78.1 (EUR € bn) | 16 |
| 2025-03-03 | FY2024 | IMIX score 2024 | 83 | 15 |
| 2025-03-03 | FY2024 | IMIX score 2023 | 81 | 15 |
| 2025-03-03 | FY2024 | Group financial targets achievement combined | 117.71% | 16 |
| 2025-03-03 | FY2024 | Funds held by others under reinsurance business assumed | 16.8 | 16 |
| 2025-03-03 | FY2024 | Expense ratio (net) in Property-Casualty reinsurance | 28.8% | 16 |
| 2025-03-03 | FY2024 | Engage with all external asset managers below expectations 2024 | 95.2 (EUR %) | 15 |
| 2025-03-03 | FY2024 | Engage top 100 non engaged portfolio emitters 2024 | 5 | 15 |
| 2025-03-03 | FY2024 | Dividend per share | € 15.40 | 15 |
| 2025-03-03 | FY2024 | Diversification Effect | (4,624) | 16 |
| 2025-03-03 | FY2024 | Distribution agreements | 1,129 | 15 |
| 2025-03-03 | FY2024 | Customer relationships | 634 | 15 |
| 2025-03-03 | FY2024 | Credit Risk Pre Diversified | 445 | 16 |
| 2025-03-03 | FY2024 | Core return on equity | 16.9 % | 15 |
| 2025-03-03 | FY2024 | Commission ratio | 28.1% | 16 |
| 2025-03-03 | FY2024 | Business Risk Pre Diversified | 212 | 16 |
| 2025-03-03 | FY2024 | Board of Management remuneration increase 2025 | 5 % | 16 |
| 2025-03-03 | FY2024 | Biometric Risk | 85 | 16 |
| 2025-03-03 | FY2024 | Average compensation based on full-time equivalent | 98 | 15 |
| 2025-03-03 | FY2024 | Additional paid-in capital | 27,732 (EUR € mn) | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Social Topics | 791 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Other | 37 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Internal asset managers | 1,354 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Governance Topics | 2,355 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Environmental Topics | 1,186 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Climate Change focus | 436 | 15 |
| 2025-03-03 | FY2024 | Active corporate engagements Allianz Investment Management | 33 | 15 |
| 2025-03-03 | FY2024 | Active asset manager engagements Climate Change focus | 72 (EUR millions) | 15 |
| 2025-03-03 | FY2024 | Active asset manager engagements | 77 (EUR millions) | 15 |
| 2024-12-12 | FY2024 | Surplus of assets over liabilities in market value balance sheet | 79 416 912 | 56 |
| 2024-12-12 | FY2024 | eligible own funds | 90 734 784 Tsd € | 56 |
| 2024-12-12 | FY2024 | Ratio of eligible own funds to SCR | 277% | 56 |
| 2024-12-12 | FY2024 | Ratio of eligible own funds to MCR | 971% | 56 |
| 2024-12-12 | FY2024 | Solvency capital requirement | 32 787 122 Tsd € | 56 |
| 2024-12-12 | FY2024 | Solvency II capital ratio | 277 % | 56 |
| 2024-12-12 | FY2024 | Solvency II ratio | 277 % | 56 |
| 2024-12-12 | FY2024 | Risk capital operational risks | 697 006 | 56 |
| 2024-12-12 | FY2024 | Risk capital reserve risk reserve strengthening need | 666 586 | 56 |
| 2024-12-12 | FY2024 | Risk capital premium risk non-catastrophe and terror | 507 854 | 56 |
| 2024-12-12 | FY2024 | Risk capital premium risk natural catastrophe | 137 377 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk combined market event | 3 979 328 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk interest rate decline 50 basis points | 132 807 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk currency depreciation 10 percent | 67 477 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk real estate value decline 10 percent | 367 645 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk financial crisis 2008 scenario | 4 628 535 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk credit spread increase 50 basis points | 739 234 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk Covid scenario | 1 995 016 | 56 |
| 2024-12-12 | FY2024 | Risk capital market risk equity price decline 30 percent | 3 520 119 | 56 |
| 2024-12-12 | FY2024 | Risk capital longevity risk | 195 705 | 56 |
| 2024-12-12 | FY2024 | Risk capital credit risk total | 445 040 | 56 |
| 2024-12-12 | FY2024 | Business risk capital | 309 164 | 56 |
| 2024-12-12 | FY2024 | Minimum capital requirement | 8 196 781 Tsd € | 56 |
| 2024-12-12 | FY2024 | Credit risk rating downgrade by one notch | 25,5% | 56 |
| 2024-12-12 | FY2024 | Credit risk increase in loss given default LGD 10 percent | 10,4% | 56 |
| 2024-12-12 | FY2024 | Expected profit future premiums | 2 517 735 | 56 |
| 2024-12-12 | FY2024 | Non-life insurance in-force risk margin | 811 557 | 56 |
| 2024-12-12 | FY2024 | Non-life insurance in-force BEL | 16 620 131 | 56 |
| 2024-12-12 | FY2024 | Life insurance in-force risk margin | 200 569 | 56 |
| 2024-12-12 | FY2024 | Life insurance in-force BEL | 292 087 | 56 |
| 2024-12-12 | FY2024 | Basic own funds | 90 734 784 | 56 |
| 2024-05-23 | FY2024 | us global insurance market share | 44.2% | 57 |
| 2024-05-23 | FY2024 | real premium growth since 2020 | +0.7% | 57 |
| 2024-05-23 | FY2024 | protection gap 2020 | USD2.8trn | 57 |
| 2024-05-23 | FY2024 | p&c segment growth 2023 | +7.1% | 57 |
| 2024-05-23 | FY2024 | life segment growth 2023 | +8.4% | 57 |
| 2024-05-23 | FY2024 | insured costs natural disasters 2023 | USD100bn+ | 57 |
| 2024-05-23 | FY2024 | insurance inflation september 2023 | +3.7% | 57 |
| 2024-05-23 | FY2024 | health segment growth 2023 | +6.6% | 57 |
| 2024-05-23 | FY2024 | global insurance growth 2023 | +7.5% | 57 |
| 2024-05-23 | FY2024 | global economic growth 2023 | +2.8% | 57 |
| 2024-05-23 | FY2024 | expected global economic growth 2024 25 | +2.7% | 57 |
| 2024-05-23 | FY2024 | China life market growth | +12.8% | 57 |
| 2024-05-23 | FY2024 | Asia life premium growth | +14.9% | 57 |
| 2024-05-23 | FY2024 | AI revenue impact insurance | +3% | 57 |
| – | FY2024 | Weighted duration defined benefit obligation | 14.3 | 55 |
| – | FY2024 | Total customers | 128 | 55 |
| – | FY2024 | Tax impact | (3,059,019) | 55 |
| – | FY2024 | Supervisory board remuneration regular member | 150 thou | 55 |
| – | FY2024 | Supervisory board remuneration deputy chairperson | 225 thou | 55 |
| – | FY2024 | Supervisory board remuneration chairperson | 450 thou | 55 |
| – | FY2024 | Supervisory board remuneration approval pct | 95.07 % | 55 |
| – | FY2024 | Supervisory board attendance fee | 1,000 | 55 |
| – | FY2024 | Solvency capitalization ratio | 209 | 55 |
| – | FY2024 | Solvency capital requirement | 44,703,373 (EUR thousands) | 55 |
| – | FY2024 | Share buyback impact | (1,500,000) | 55 |
| – | FY2024 | SCR 2024 | 44,703,373 | 55 |
| – | FY2024 | SCR 2023 | 43,484,650 | 55 |
| – | FY2024 | Remuneration cap regular board member | 6,000 thou | 55 |
| – | FY2024 | Remuneration cap chairperson | 11,750 thou | 55 |
| – | FY2024 | Rate of medical cost trend | 5.6 | 55 |
| – | FY2024 | Rate of compensation increase | 1.9 | 55 |
| – | FY2024 | Plan assets total | 14,590,512 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: real estate (%) | 5.2 | 55 |
| – | FY2024 | Plan assets: real estate | 763,352 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: other (%) | 1.7 | 55 |
| – | FY2024 | Plan assets: other | 246,802 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: life insurance investment products (%) | 10.4 | 55 |
| – | FY2024 | Plan assets: life insurance investment products | 1,518,085 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: equity securities, quoted (%) | 11.1 | 55 |
| – | FY2024 | Plan assets: equity securities, quoted | 1,620,348 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: equity securities, non-quoted (%) | 0.4 | 55 |
| – | FY2024 | Plan assets: equity securities, non-quoted | 61,783 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: debt securities, quoted (%) | 23.2 | 55 |
| – | FY2024 | Plan assets: debt securities, quoted | 3,390,238 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: debt securities, non-quoted (%) | 8.9 | 55 |
| – | FY2024 | Plan assets: debt securities, non-quoted | 1,299,991 (EUR € thou) | 55 |
| – | FY2024 | Plan assets: annuity contracts (%) | 39.0 | 55 |
| – | FY2024 | Plan assets: annuity contracts | 5,689,913 (EUR € thou) | 55 |
| – | FY2024 | Own funds movement - regulatory changes | (751,448) | 55 |
| – | FY2024 | Own funds | 93,212,185 | 55 |
| – | FY2024 | New business contribution | 2,225,352 | 55 |
| – | FY2024 | Management actions impact | (481,179) | 55 |
| – | FY2024 | interest received associates/JV prior year | 145 mn | 55 |
| – | FY2024 | interest received associates/JV | 150 mn | 55 |
| – | FY2024 | expected in-force contribution | 3,700,725 | 55 |
| – | FY2024 | estimated future cash flows 2030-2034 | 5,508,308 (EUR € thou) | 55 |
| – | FY2024 | estimated future cash flows 2029 | 1,134,509 (EUR € thou) | 55 |
| – | FY2024 | estimated future cash flows 2028 | 1,120,100 (EUR € thou) | 55 |
| – | FY2024 | estimated future cash flows 2027 | 1,093,999 (EUR € thou) | 55 |
| – | FY2024 | estimated future cash flows 2026 | 1,043,058 (EUR € thou) | 55 |
| – | FY2024 | estimated future cash flows 2025 | 1,012,681 (EUR € thou) | 55 |
| – | FY2024 | eligible own funds end 2024 | 93,212,185 | 55 |
| – | FY2024 | eligible own funds beginning 2024 | 89,558,120 | 55 |
| – | FY2024 | discount rate United Kingdom | 5.5 | 55 |
| – | FY2024 | discount rate Switzerland | 1.0 | 55 |
| – | FY2024 | discount rate Germany short duration | 3.3 | 55 |
| – | FY2024 | discount rate Germany long duration | 3.4 | 55 |
| – | FY2024 | defined contribution plans expenses | 312,612 (EUR € thou) | 55 |
| – | FY2024 | defined benefit obligation increase one year life expectancy | 547,070 | 55 |
| – | FY2024 | defined benefit obligation increase +50bps discount rate | 1,138,805 | 55 |
| – | FY2024 | defined benefit obligation increase +25bps salary | 39,930 | 55 |
| – | FY2024 | defined benefit obligation decrease -50bps discount rate | 1,018,258 | 55 |
| – | FY2024 | Deferred tax liabilities MVBS | 10,921,656 | 55 |
| – | FY2024 | Dedicated assets group level | 8.9 bn | 55 |
| – | FY2024 | Debt costs | (908,833) | 55 |
| – | FY2024 | CEO to employee remuneration ratio 2024 | 94 | 55 |
| – | FY2024 | CEO to employee remuneration ratio 2023 | 68 | 55 |
| – | FY2024 | Capital management impact | (7,005,503) | 55 |
| – | FY2024 | Board variable remuneration target achievement cap | 150 % | 55 |
| – | FY2024 | Board variable remuneration annual bonus cap | 150 % | 55 |
| – | FY2024 | Board member to employee remuneration ratio 2024 | 50 | 55 |
| – | FY2024 | Board member to employee remuneration ratio 2023 | 36 | 55 |
| – | FY2024 | Board management shareholding obligation regular member | 700 % | 55 |
| – | FY2024 | Board management shareholding obligation chairperson | 800 % | 55 |
| – | FY2024 | Board management base salary regular member | 1,024 thou | 55 |
| – | FY2024 | Board management base salary chairperson | 4,013 thou | 55 |
| – | FY2024 | BlackRock voting rights | 6.90 % | 55 |
| – | FY2024 | BlackRock total position | 6.98 % | 55 |
| – | FY2024 | BlackRock shares | 26,640,268 | 55 |
| – | FY2024 | BlackRock instruments 38(1) no. 2 votes | 38,142 | 55 |
| – | FY2024 | BlackRock instruments 38(1) no. 2 | 0.01 % | 55 |
| – | FY2024 | BlackRock instruments 38(1) no. 1 votes | 284,461 | 55 |
| – | FY2024 | BlackRock Instruments 38 1 No 1 | 0.07 % | 55 |
| – | FY2024 | Assumption changes experience variances | (771,993) | 55 |
| – | FY2024 | Asset-backed securities mortgage-backed securities | 31,347,188 (EUR thousands) | 55 |
| – | FY2024 | Total reinsurance recoverables | 19,131,043 | 55 |
| – | FY2024 | Total FTEs allocated to group-related key function tasks | 317.7 | 55 |
| – | FY2024 | Tier 3 own funds % | 1.9 | 55 |
| – | FY2024 | Tier 2 own funds % | 13.8 | 55 |
| – | FY2024 | Tier 1 unrestricted own funds % | 79.5 | 55 |
| – | FY2024 | Tier 1 restricted own funds % | 4.8 | 55 |
| – | FY2024 | Solvency II capitalization ratio | 209% | 17 |
| – | FY2024 | Solvency II capitalization | 209% | 55 |
| – | FY2024 | SII ratio (%) | 211 | 52 |
| – | FY2024 | Reinsurance recoverables non-life | 13,427,130 | 55 |
| – | FY2024 | Reinsurance recoverables life | 5,084,084 | 55 |
| – | FY2024 | Reinsurance recoverables health non-life | 619,829 | 55 |
| – | FY2024 | Reinsurance recoverables health life | 144,598 | 55 |
| – | FY2024 | Ratio of total eligible own funds to total group SCR | 2.09 | 55 |
| – | FY2024 | Ratio of eligible own funds to minimum consolidated group SCR | 2.74 | 55 |
| – | FY2024 | Number of key functions outsourcing agreements | 66 | 55 |
| – | FY2024 | Number of additional material intra-group outsourcing agreements | 11 | 55 |
| – | FY2024 | Number of FTEs allocated to Risk Management group-related key function tasks | 112.2 | 55 |
| – | FY2024 | FTEs in Legal key function tasks | 24.9 | 55 |
| – | FY2024 | FTEs in Internal Audit key function tasks | 29.9 | 55 |
| – | FY2024 | FTEs in Compliance key function tasks | 43.0 | 55 |
| – | FY2024 | FTEs in Actuarial key function tasks | 25.5 | 55 |
| – | FY2024 | FTEs in Accounting and Reporting key function tasks | 82.2 | 55 |
| – | FY2024 | CIFS outsourcing agreements | 812 | 55 |
| – | FY2024 | Normalized CSM growth (%) | 6.1 | 17 |
| – | FY2024 | NatCat (%) | 2.8 | 52 |
| – | FY2024 | NBM (%) | 5.8 | 52 |
| – | FY2024 | Loss ratio (%) | 69.3 | 17 |
| – | FY2024 | Internal growth (%) | 7.3 | 52 |
| – | FY2024 | Financial conglomerate capitalization ratio | 209% | 55 |
| – | FY2024 | Expense ratio (%) | 24.2 | 17 |
| – | FY2024 | ER (%) | 24.2 | 52 |
| – | FY2024 | DPS (EUR) | 15.21 | 52 |
| – | FY2024 | Cost-income ratio (%) | 61.1 | 17 |
| – | FY2024 | Core return on equity Life/Health (%) | 16.3 (EUR millions) | 17 |
| – | FY2024 | Core return on equity (%) | 16.9 (EUR millions) | 17 |
| – | FY2024 | Core EPS (EUR) | 25.37 | 52 |
| – | FY2024 | Combined ratio (%) | 93.4 | 17 |
| – | FY2024 | CoR (%) | 93.7 | 52 |
| – | FY2024 | CIR (%) | 61.1 | 52 |
| 2025-02-28 | 2024-Q4 | Third party assets under management | 1,920 (EUR EUR bn) | 53 |
| 2025-02-28 | 2024-Q4 | Solvency II ratio | 209 | 53 |
| 2025-02-28 | 2024-Q4 | Loss ratio property casualty | 70.7 | 53 |
| 2025-02-28 | 2024-Q4 | expense ratio property casualty | 24.1 | 53 |
| 2025-02-28 | 2024-Q4 | core return on equity | 16.9 (EUR %) | 53 |
| 2025-02-28 | 2024-Q4 | Combined ratio property casualty | 94.7 | 53 |
| 2025-02-28 | 2024-Q4 | Assets under management | 2,448 (EUR EUR bn) | 53 |
| 2025-02-28 | 2024-Q4 | value of new business | 4.7 billion euros | 51 |
| 2025-02-28 | 2024-Q4 | Third-party assets under management | 1,920 (EUR € bn) | 51 |
| 2025-02-28 | 2024-Q4 | Solvency II capitalization ratio | 209% | 51 |
| 2025-02-28 | 2024-Q4 | new business margin (Life/Health) | 5.7% | 51 |
| 2025-02-28 | 2024-Q4 | new business margin (Life/Health 4Q) | 5.5% | 51 |
| 2025-02-28 | 2024-Q4 | Cost-income ratio (Asset Management) | 61.1% | 51 |
| 2025-02-28 | 2024-Q4 | cost-income ratio (Asset Management 4Q) | 60.0% | 51 |
| 2025-02-28 | 2024-Q4 | Core return on equity | 16.9% | 51 |
| 2025-02-28 | 2024-Q4 | combined ratio (Property-Casualty) | 93.4% | 51 |
| 2025-02-28 | 2024-Q4 | combined ratio (Property-Casualty 4Q) | 94.7% | 51 |
| – | 2024-Q4 | Third-party assets under management | 1,920 € bn | 54 |
| – | 2024-Q4 | Solvency II capitalization ratio | 209% | 54 |
| – | 2024-Q4 | Shareholders' equity | 60.3 € bn | 54 |
| – | 2024-Q4 | new business margin (Life/Health) | 5.7% | 54 |
| – | 2024-Q4 | Cost-income ratio (Asset Management) | 61.1% | 54 |
| – | 2024-Q4 | Core return on equity | 16.9% | 54 |
| – | 2024-Q4 | Contractual service margin (net) | 34.5 € bn | 54 |
| – | 2024-Q4 | combined ratio (Property-Casualty) | 93.4% | 54 |
| 2024-11-13 | 2024-Q3 | assets under management for third parties | 1,840 Billionen Euro | 14 |
| 2024-11-13 | 2024-Q3 | adjusted return on equity | 17,5% | 14 |
| 2024-11-13 | 2024-Q3 | Contractual service margin (CSM) | 54,2 Milliarden Euro | 14 |
| 2024-11-13 | 2024-Q3 | Solvency II capitalisation ratio | 209% | 14 |
| 2024-11-13 | 2024-Q3 | loss ratio P&C | 93,5% | 14 |
| 2024-11-13 | 2024-Q3 | PVNBP Life/Health | 19,5 Milliarden Euro | 14 |
| 2024-11-13 | 2024-Q3 | New business margin Life/Health | 6,1% | 14 |
| 2024-11-13 | 2024-Q3 | Cost-income ratio Asset Management | 61,0% | 14 |
| 2024-08-08 | 2024-Q2 | Contractual service margin (net) | 33,7 | 12 |
| 2024-08-08 | 2024-Q2 | Solvency II capitalisation ratio | 206% | 12 |
| 2024-08-08 | 2024-Q2 | Combined ratio | 92,7% | 12 |
| 2024-08-08 | 2024-Q2 | New business margin Life/Health | 5,7% | 12 |
| 2024-08-08 | 2024-Q2 | net flows Asset Management (6M) | 48,4 (EUR Mrd €) | 12 |
| 2024-08-08 | 2024-Q2 | Third-party assets under management | 1.803 | 12 |
| 2024-08-08 | 2024-Q2 | Equity | 55,5 | 12 |
| 2024-08-08 | 2024-Q2 | Adjusted return on equity | 17,5% | 12 |
| 2024-08-08 | 2024-Q2 | Cost-income ratio Asset Management | 61,8% | 12 |
| 2024-08-07 | 2024-H1 | total business volume | 91,045 | 10 |
| 2024-08-07 | 2024-H1 | shares diluted | 390,631,470 | 10 |
| 2024-08-07 | 2024-H1 | shareholders core net income | 5,049 | 10 |
| 2024-08-07 | 2024-H1 | Third-party assets under management | 1,803 (EUR € bn) | 10 |
| 2024-08-07 | 2024-H1 | Solvency II capitalization ratio | 206 | 10 |
| 2024-08-07 | 2024-H1 | Loss ratio | 68.3 | 10 |
| 2024-08-07 | 2024-H1 | Expense ratio | 24.4 | 10 |
| 2024-08-07 | 2024-H1 | cost-income ratio - Asset Management | 61.8 | 10 |
| 2024-08-07 | 2024-H1 | core return on equity - Life/Health | 16.9 (EUR %) | 10 |
| 2024-08-07 | 2024-H1 | Core return on equity | 17.5 (EUR %) | 10 |
| 2024-08-07 | 2024-H1 | Combined ratio | 92.7 | 10 |
| 2024-05-15 | 2024-Q1 | Contractual service margin (net) | 33,2 Mrd € | 11 |
| 2024-05-15 | 2024-Q1 | Solvency II capital ratio | 203% | 11 |
| 2024-05-15 | 2024-Q1 | Combined ratio | 91,9% | 11 |
| 2024-05-15 | 2024-Q1 | New business margin | 5,7% | 11 |
| 2024-05-15 | 2024-Q1 | Third-party assets under management | 1.784 Billionen € | 11 |
| 2024-05-15 | 2024-Q1 | Adjusted return on equity (annualized) | 17,4% | 11 |
| 2024-05-15 | 2024-Q1 | Cost-to-income ratio (Asset Management) | 61,1% | 11 |
| 2026-07-23 | FY2023 | Western European share global high wealth class 2023 | 20.8% | 37 |
| 2026-07-23 | FY2023 | Western European share global high wealth class 2003 | 36.9% | 37 |
| 2026-07-23 | FY2023 | Top 10 percent wealth share national average 2023 | 61.1% | 37 |
| 2026-07-23 | FY2023 | Top 10 percent wealth share national average 2003 | 60.6% | 37 |
| 2026-07-23 | FY2023 | Sea level rise exposed property price discount | -7% | 37 |
| 2026-07-23 | FY2023 | North American share global high wealth class | 30.8% | 37 |
| 2026-07-23 | FY2023 | Mean to median ratio national average 2023 | 3.1 | 37 |
| 2026-07-23 | FY2023 | Mean to median ratio national average 2003 | 3.2 | 37 |
| 2026-07-23 | FY2023 | Hurricane exposed transaction probability decline | -7% | 37 |
| 2026-07-23 | FY2023 | Hurricane exposed home price increase years following | +5% | 37 |
| 2026-07-23 | FY2023 | Hurricane exposed home price increase peak year 2 | +10% | 37 |
| 2026-07-23 | FY2023 | Global low wealth class growth | +8% | 37 |
| 2026-07-23 | FY2023 | Global high wealth class emerging economies share | 34% | 37 |
| 2026-07-23 | FY2023 | Flood zone housing price penalty damaged immediate | -17-22% | 37 |
| 2026-07-23 | FY2023 | Flood zone housing price penalty by 2017 non damaged | -8% | 37 |
| 2026-07-23 | FY2023 | Elevation effect pre Katrina | +1.4% | 37 |
| 2026-07-23 | FY2023 | Elevation effect post Katrina | +4.6% | 37 |
| 2026-07-23 | FY2023 | Chinese share global middle wealth class | 33% | 37 |
| 2026-07-23 | FY2023 | Chinese share global high wealth class | 23.4% | 37 |
| 2026-07-23 | FY2023 | Chinese population in global middle wealth class | 20% | 37 |
| 2026-07-23 | FY2023 | Asian ex Japan China share global middle wealth class | 25% | 37 |
| 2026-07-23 | FY2023 | Asian ex Japan China population in global middle wealth class | 9% | 37 |
| 2024-02-26 | FY2023 | training hours target | 43 | 7 |
| 2024-02-26 | FY2023 | total remuneration of Supervisory Board members 2023 | € 3.5 mn | 7 |
| 2024-02-26 | FY2023 | total remuneration of Board of Management 2023 excluding pension service cost | € 36 mn | 7 |
| 2024-02-26 | FY2023 | total liabilities | 919,594 | 7 |
| 2024-02-26 | FY2023 | total external leavers | 21,181 | 7 |
| 2024-02-26 | FY2023 | total assets | 983,174 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | third party net inflows | 21.5 bn | 7 |
| 2024-02-26 | FY2023 | Third party assets under management | 1.7 tn | 7 |
| 2024-02-26 | FY2023 | shares outstanding | 391,718,983 | 8 |
| 2024-02-26 | FY2023 | shareholders equity | 58,477 | 7 |
| 2024-02-26 | FY2023 | shareholders core net income | 9,101 | 7 |
| 2024-02-26 | FY2023 | shareholder total return | 27% | 7 |
| 2024-02-26 | FY2023 | share capital | € 1,169,920,000 | 8 |
| 2024-02-26 | FY2023 | remunerations and other benefits to former Board members 2023 | € 12 mn | 7 |
| 2024-02-26 | FY2023 | own shares held | 260,394 | 8 |
| 2024-02-26 | FY2023 | operating profit target 2023 | 14.20 billion | 7 |
| 2024-02-26 | FY2023 | operating profit actual 2023 | 14.75 billion | 7 |
| 2024-02-26 | FY2023 | operating profit achievement 2023 | 107.69% | 7 |
| 2024-02-26 | FY2023 | operating fee and commission result | 7,639 | 7 |
| 2024-02-26 | FY2023 | new business | 4.0 bn | 7 |
| 2024-02-26 | FY2023 | net income attributable to shareholders target 2023 | 7.9 – 8.9 billion | 7 |
| 2024-02-26 | FY2023 | net income attributable to shareholders actual 2023 | 8.54 billion | 7 |
| 2024-02-26 | FY2023 | net income achievement 2023 | 100.00% | 7 |
| 2024-02-26 | FY2023 | mutual mentoring arrangements | 700 (EUR millions) | 7 |
| 2024-02-26 | FY2023 | interest rate on money market securities | 4.4 | 7 |
| 2024-02-26 | FY2023 | group financial target achievement 2023 | 103.85% | 7 |
| 2024-02-26 | FY2023 | executive population with Personal Development Plan | 83.87 % | 7 |
| 2024-02-26 | FY2023 | employees SWP coverage | 85% | 7 |
| 2024-02-26 | FY2023 | brand value | USD 20 bn | 7 |
| 2024-02-26 | FY2023 | average shareholding exposure board members | approximately 800% of base salary for Chairperson, approximately 700% of base salary for regular Board member | 7 |
| 2024-02-26 | FY2023 | advances granted to Board members | € 300 thou | 7 |
| 2024-02-26 | FY2023 | Work Well Index plus | 76 % | 7 |
| 2024-02-26 | FY2023 | WWI+ | 76 | 8 |
| 2024-02-26 | FY2023 | total present value of minimum lease payments | 2,730 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | total plan assets | 14,445 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | total operating lease payments | 5,909 | 7 |
| 2024-02-26 | FY2023 | total interest on lease payments | 329 | 7 |
| 2024-02-26 | FY2023 | total future minimum lease payments | 3,059 | 7 |
| 2024-02-26 | FY2023 | total cash outflow for leases | € 516 mn | 7 |
| 2024-02-26 | FY2023 | Total business volume | 161,700 | 7 |
| 2024-02-26 | FY2023 | Third party assets under management | 1,712 (EUR € bn) | 7 |
| 2024-02-26 | FY2023 | Sustainable Solutions revenues | 3,026 (EUR € mn) | 8 |
| 2024-02-26 | FY2023 | Subordinated liabilities | 17.6 | 8 |
| 2024-02-26 | FY2023 | Solvency II capitalization ratio | 206 | 7 |
| 2024-02-26 | FY2023 | Solvency II capitalization ratio | 206 | 7 |
| 2024-02-26 | FY2023 | Shareholders' equity | 58,477 | 7 |
| 2024-02-26 | FY2023 | Shareholders equity | 41.4 | 8 |
| 2024-02-26 | FY2023 | Real estate | 25.7 | 7 |
| 2024-02-26 | FY2023 | Real estate | 910 | 7 |
| 2024-02-26 | FY2023 | rate of medical cost trend | 5.6 | 7 |
| 2024-02-26 | FY2023 | rate of compensation increase | 1.9 | 7 |
| 2024-02-26 | FY2023 | PwC total fees 2023 | 93.0 | 7 |
| 2024-02-26 | FY2023 | PwC tax services fees 2023 | 1.5 | 7 |
| 2024-02-26 | FY2023 | PwC other services fees 2023 | 5.4 | 7 |
| 2024-02-26 | FY2023 | PwC other attestation services fees 2023 | 6.8 | 7 |
| 2024-02-26 | FY2023 | PwC audit services fees 2023 | 79.3 | 7 |
| 2024-02-26 | FY2023 | Property Casualty total business volume | 77 bn | 7 |
| 2024-02-26 | FY2023 | Present value of minimum lease payments (More than five years) | 1,111 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Present value of minimum lease payments (Less than one year) | 461 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Present value of minimum lease payments (Between one and five years) | 1,159 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Own Funds | 89.6 | 7 |
| 2024-02-26 | FY2023 | Other investments | 28.5 (EUR bn) | 8 |
| 2024-02-26 | FY2023 | Other | (30) | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (One year and less) | 1,110 | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (More than 5 years) | 1,730 | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (Between 4 and up to 5 years) | 502 | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (Between 3 and up to 4 years) | 765 | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (Between 2 and up to 3 years) | 855 | 7 |
| 2024-02-26 | FY2023 | Operating lease payments (Between 1 and up to 2 years) | 948 | 7 |
| 2024-02-26 | FY2023 | Non-technical result | 8,119,195 | 8 |
| 2024-02-26 | FY2023 | Net reinsurance contract assets | 13,810 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Money market securities | 1,103 | 7 |
| 2024-02-26 | FY2023 | Life insurance investment products | 1,440 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Lease income for operating leases | € 1,270 mn | 7 |
| 2024-02-26 | FY2023 | Investments | 125.8 (EUR bn) | 8 |
| 2024-02-26 | FY2023 | Investment result | 8,790,519 (EUR € thou) | 8 |
| 2024-02-26 | FY2023 | Interest on lease payments (More than five years) | 133 | 7 |
| 2024-02-26 | FY2023 | Interest on lease payments (Less than one year) | 51 | 7 |
| 2024-02-26 | FY2023 | Interest on lease payments (Between one and five years) | 145 | 7 |
| 2024-02-26 | FY2023 | Insurance revenue | 91,251 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Insurance reserves | 23.1 | 8 |
| 2024-02-26 | FY2023 | IMIX Inclusive Meritocracy Index | 81 % | 7 |
| 2024-02-26 | FY2023 | IMIX | 81 | 8 |
| 2024-02-26 | FY2023 | GenZ GenY representation | 34.31% | 7 |
| 2024-02-26 | FY2023 | GPTW certified entities countries | 26 | 7 |
| 2024-02-26 | FY2023 | GPTW certified entities | 43 | 7 |
| 2024-02-26 | FY2023 | GPTW certified entities | 43 | 8 |
| 2024-02-26 | FY2023 | GPTW Trust Index | 82 | 8 |
| 2024-02-26 | FY2023 | Future minimum lease payments (More than five years) | 1,244 | 7 |
| 2024-02-26 | FY2023 | Future minimum lease payments (Less than one year) | 512 | 7 |
| 2024-02-26 | FY2023 | Future minimum lease payments (Between one and five years) | 1,303 | 7 |
| 2024-02-26 | FY2023 | Funds held by others | 15.0 | 8 |
| 2024-02-26 | FY2023 | Equity securities (Quoted) | 1,444 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Equity securities (Non-quoted) | 43 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Equities | 48.1 | 7 |
| 2024-02-26 | FY2023 | Discount rate (United Kingdom) | 4.5 | 7 |
| 2024-02-26 | FY2023 | Discount rate (Switzerland) | 1.5 | 7 |
| 2024-02-26 | FY2023 | Discount rate (Germany, short duration) | 3.2 | 7 |
| 2024-02-26 | FY2023 | Discount rate (Germany, long duration) | 3.2 | 7 |
| 2024-02-26 | FY2023 | Debt securities (Quoted) | 3,233 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Debt securities (Non-quoted) | 2,197 (EUR € mn) | 7 |
| 2024-02-26 | FY2023 | Debt instruments | 557.1 (EUR € bn) | 7 |
| 2024-02-26 | FY2023 | Core return on equity | 16.0 (EUR %) | 7 |
| 2024-02-26 | FY2023 | Carrying amount investments | 120.6 (EUR bn) | 8 |
| 2024-02-26 | FY2023 | Capitalization ratio (2022) | 262 | 8 |
| 2024-02-26 | FY2023 | Capitalization ratio | 265 | 8 |
| 2024-02-26 | FY2023 | Capital requirement | 43.5 (EUR € bn) | 7 |
| 2024-02-26 | FY2023 | CSM as of 31 December 2023 | 53,818 | 7 |
| 2024-02-26 | FY2023 | Assets under management | 2,224 (EUR € bn) | 7 |
| 2024-02-26 | FY2023 | Annuity contracts | 5,208 | 7 |
| 2024-02-26 | FY2023 | Allianz NEO local networks | 20 | 7 |
| 2024-02-26 | FY2023 | Allianz GRACE local networks | 81 | 7 |
| 2024-02-26 | FY2023 | Allianz Engage local networks | 11 | 7 |
| 2024-02-26 | FY2023 | Allianz Beyond local networks | 12 | 7 |
| – | FY2023 | Internal growth total business volume | 8.0 | 9 |
| – | FY2023 | Internal growth Property-Casualty | 11.2 | 9 |
| – | FY2023 | Internal growth Life/Health | 5.6 | 9 |
| – | FY2023 | Internal growth Asset Management | 2.4 | 9 |
| – | FY2023 | Cost-income ratio Asset Management 2022 | 61.2 | 9 |
| – | FY2023 | Cost-income ratio Asset Management | 61.3 | 9 |
| – | FY2023 | Core return on equity Life/Health 2022 | 14.0 (EUR %) | 9 |
| – | FY2023 | Core return on equity Life/Health | 16.3 (EUR %) | 9 |
| – | FY2023 | Core return on equity Group 2022 | 12.7 (EUR %) | 9 |
| – | FY2023 | Core return on equity Group | 16.0 (EUR %) | 9 |
| 2024-02-23 | 2023-Q4 | Third-party assets under management | 1,712 (EUR € bn) | 58 |
| 2024-02-23 | 2023-Q4 | Solvency II ratio | 206% | 60 |
| 2024-02-23 | 2023-Q4 | Solvency II capitalization ratio | 206% | 58 |
| 2024-02-23 | 2023-Q4 | Shareholders' equity | 58.5 | 58 |
| 2024-02-23 | 2023-Q4 | new business margin (Life/Health) | 5.9% | 58 |
| 2024-02-23 | 2023-Q4 | Loss ratio | 69.3% | 60 |
| 2024-02-23 | 2023-Q4 | Expense ratio | 24.6% | 60 |
| 2024-02-23 | 2023-Q4 | Dividend per share | 13.80 | 58 |
| 2024-02-23 | 2023-Q4 | Cost-income ratio (Asset Management) | 61.3% | 58 |
| 2024-02-23 | 2023-Q4 | Core return on equity | 16.0% | 58 |
| 2024-02-23 | 2023-Q4 | Core return on equity | 16.0% | 60 |
| 2024-02-23 | 2023-Q4 | Contractual service margin (net) | 32.7 | 58 |
| 2024-02-23 | 2023-Q4 | combined ratio (Property-Casualty) | 93.8% | 58 |
| 2024-02-23 | 2023-Q4 | Combined ratio | 93.8% | 60 |
| 2023-12-14 | 2023-Q4 | Volatility adjustment impact non-life | reduction of € 598,533 thou | 62 |
| 2023-12-14 | 2023-Q4 | Volatility adjustment impact life | reduction of € 1,368,548 thou | 62 |
| 2023-12-14 | 2023-Q4 | Solvency II SCR impact zero volatility adjustment | increase of € 3,469,786 thou to € 46,954,436 thou | 62 |
| 2023-12-14 | 2023-Q4 | Solvency capital requirement | 43,484,650 (EUR thousands) | 62 |
| 2023-12-14 | 2023-Q4 | Loans to associates and JVs | € 2,582 mn | 62 |
| 2023-12-14 | 2023-Q4 | Interest received associates JVs | € 145 mn | 62 |
| 2023-12-14 | 2023-Q4 | Eligible own funds impact zero volatility adjustment | increase of € 939,569 thou to € 90,497,689 thou | 62 |
| 2023-12-14 | 2023-Q4 | eligible own funds | 99,724,143 | 62 |
| 2023-12-14 | 2023-Q4 | Deferred tax assets recoverability assessment | € 2,128,415 thou substantiated by deferred tax liabilities of € 45,280,539 thou | 62 |
| 2023-12-14 | 2023-Q4 | Corporate and other operating result | (473,695) | 62 |
| 2023-12-14 | 2023-Q4 | Capitalization ratio excl. volatility adjustment | 193% | 62 |
| 2023-12-14 | 2023-Q4 | Capitalization ratio excl. transitional | 206% | 62 |
| 2023-12-14 | 2023-Q4 | Capitalization ratio | 229% | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock voting rights shares | 6.75% | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock shares absolute | 27,586,790 | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock instruments 38 1 2 WpHG | 0.003% | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock instruments 38 1 2 absolute | 12,388 | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock instruments 38 1 1 WpHG | 0.06% | 62 |
| 2023-12-14 | 2023-Q4 | BlackRock instruments 38 1 1 absolute | 233,827 | 62 |
| 2023-12-14 | 2023-Q4 | Asset management operating revenues | 8,085,515 (EUR thousands) | 62 |
| 2023-12-14 | 2023-Q4 | Asset management operating profit | 3,126,103 (EUR thousands) | 62 |
| 2023-12-14 | 2023-Q4 | ABS portfolio investment grade | 97% | 62 |
| 2023-12-14 | 2023-Q4 | ABS portfolio AA or better | 71% | 62 |
| 2023-12-14 | 2023-Q4 | Total liabilities | 674,247,599 | 62 |
| 2023-12-14 | 2023-Q4 | total cash outflow for leases | 515,904 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | Total assets | 764,795,215 (EUR in thousands) | 62 |
| 2023-12-14 | 2023-Q4 | Total Group SCR | 43,484,650 | 62 |
| 2023-12-14 | 2023-Q4 | Tier 3 Own Funds | 1,610,028 | 62 |
| 2023-12-14 | 2023-Q4 | Tier 2 Own Funds | 10,434,054 | 62 |
| 2023-12-14 | 2023-Q4 | Tier 1 unrestricted Own Funds | 70,241,100 | 62 |
| 2023-12-14 | 2023-Q4 | Tier 1 restricted Own Funds | 5,758,486 | 62 |
| 2023-12-14 | 2023-Q4 | Solvency Capital Requirement | 43,484,650 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | Real estate allocation | 6.3 | 62 |
| 2023-12-14 | 2023-Q4 | Ratio of Eligible Own Funds to Total Group SCR | 2.29 | 62 |
| 2023-12-14 | 2023-Q4 | rate of medical cost trend | 5.6 | 62 |
| 2023-12-14 | 2023-Q4 | rate of compensation increase | 1.9 | 62 |
| 2023-12-14 | 2023-Q4 | Other allocation | (0.2) | 62 |
| 2023-12-14 | 2023-Q4 | Minimum consolidated MCR | 26,674,374 | 62 |
| 2023-12-14 | 2023-Q4 | Minimum consolidated Group solvency capital requirement | 26,674,374 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | Minimum consolidated Group SCR | 26,674,374 | 62 |
| 2023-12-14 | 2023-Q4 | MVBS excess of assets over liabilities | 90,547,616 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | Life insurance investment products allocation | 10.0 (EUR in %) | 62 |
| 2023-12-14 | 2023-Q4 | Lease income for operating leases | 1,270,408 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | IFRS excess of assets over liabilities | 63,579,605 (EUR € thou) | 62 |
| 2023-12-14 | 2023-Q4 | Group SCR | 43,484,650 | 62 |
| 2023-12-14 | 2023-Q4 | Excess of assets over liabilities | 90,547,616 (EUR in thousands) | 62 |
| 2023-12-14 | 2023-Q4 | Equity securities allocation | 10.0 (EUR in %) | 62 |
| 2023-12-14 | 2023-Q4 | Eligible Own Funds including other sectors Group SCR | 99,724,143 | 62 |
| 2023-12-14 | 2023-Q4 | Eligible Own Funds excluding other sectors SCR | 88,043,668 | 62 |
| 2023-12-14 | 2023-Q4 | Eligible Own Funds excluding other sectors MCR | 81,334,461 | 62 |
| 2023-12-14 | 2023-Q4 | Discount rate | 3.2 | 62 |
| 2023-12-14 | 2023-Q4 | Debt securities quoted allocation | 22.4 (EUR in %) | 62 |
| 2023-12-14 | 2023-Q4 | Debt securities non quoted allocation | 15.2 (EUR in %) | 62 |
| 2023-12-14 | 2023-Q4 | Basic Own Funds after deductions | 88,043,668 | 62 |
| 2023-12-14 | 2023-Q4 | Annuity contracts allocation | 36.1 | 62 |
| – | 2023-Q4 | Third-party assets under management | 1,712 (EUR € bn) | 61 |
| – | 2023-Q4 | Solvency II capitalization ratio | 206% | 61 |
| – | 2023-Q4 | Shareholders' equity | 58.5 | 61 |
| – | 2023-Q4 | SII ratio | 206 | 59 |
| – | 2023-Q4 | Run-off | -4.2 | 59 |
| – | 2023-Q4 | new business margin (Life/Health) | 5.9% | 61 |
| – | 2023-Q4 | Net flows | -7 | 59 |
| – | 2023-Q4 | NatCat | 4.2 | 59 |
| – | 2023-Q4 | NBM | 5.9 | 59 |
| – | 2023-Q4 | Internal growth | 9.8 | 59 |
| – | 2023-Q4 | ER | 23.5 | 59 |
| – | 2023-Q4 | Dividend per share | 11.40 | 61 |
| – | 2023-Q4 | Discounting impact | -2.5 | 59 |
| – | 2023-Q4 | DPS | 13.80 | 59 |
| – | 2023-Q4 | Cost-income ratio (Asset Management) | 61.3% | 61 |
| – | 2023-Q4 | Core return on equity | 16.0% | 61 |
| – | 2023-Q4 | Contractual service margin (net) | 32.7 | 61 |
| – | 2023-Q4 | combined ratio (Property-Casualty) | 93.8% | 61 |
| – | 2023-Q4 | CSM | 52.6 | 59 |
| – | 2023-Q4 | CR | 94.9 | 59 |
| – | 2023-Q4 | CIR | 60.5 | 59 |
| 2023-11-10 | 2023-Q3 | Total assets under management | 2,162 Billionen Euro | 6 |
| 2023-11-10 | 2023-Q3 | assets under management for third parties | 1,670 Billionen Euro | 6 |
| 2023-11-10 | 2023-Q3 | Solvency II capitalisation ratio | 212% | 6 |
| 2023-11-10 | 2023-Q3 | Equity | 56,1 Milliarden Euro | 6 |
| 2023-08-08 | 2023-H1 | Total commitments | 49,064 | 2 |
| 2023-08-08 | 2023-H1 | Total business volume | 85,588 | 2 |
| 2023-08-08 | 2023-H1 | Third-party assets under management | 1,662 (EUR billions) | 2 |
| 2023-08-08 | 2023-H1 | Solvency II capitalization ratio | 208 | 2 |
| 2023-08-08 | 2023-H1 | Shareholders core net income | 4,690 | 2 |
| 2023-08-08 | 2023-H1 | Other commitments | 4,212 | 2 |
| 2023-08-08 | 2023-H1 | Insurance contract liabilities | 754,829 | 2 |
| 2023-08-08 | 2023-H1 | Core return on equity | 16.7 (EUR %) | 2 |
| 2023-08-08 | 2023-H1 | Core earnings per share | 11.40 | 2 |
| 2023-08-08 | 2023-H1 | Core diluted earnings per share | 11.38 | 2 |
| 2023-08-08 | 2023-H1 | Contractual service margin | 54,055 | 2 |
| 2023-08-08 | 2023-H1 | Commitments to purchase debt investments | 8,606 (EUR in millions) | 2 |
| 2023-08-08 | 2023-H1 | Commitments to acquire interests in joint ventures, associates and equity investments | 36,246 (EUR in millions) | 2 |
Guidance Tracking (latest per metric/period · 22/36)#
All management forecasts (guidance) and their later outcome. Types: fiscal-year targets as well as quarterly/half-year targets; per metric and period the most recent statement applies, older versions can be expanded. The status is checked automatically against the actuals reported later: open (period still running), met, beaten, missed. For ranges (“X to Y”) reaching the range counts. Logged neutrally, no estimate of our own, no assessment.
| For period | Guided on | Metric | Guided | Verdict | Direction | Source |
|---|---|---|---|---|---|---|
| FY2026 | 2026-08-07 | Operating profit | 1–17 | pending | confirmed | 36 |
| FY2026 | 2026-08-05 | Operating profit | 17,400 | pending | confirmed | 31 |
| FY2026 | 2026-03-02 | Combined ratio | 92–93% | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Property-Casualty total business volume growth | 6% | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Property-Casualty operating profit | 9,000 | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Life/Health normalized CSM growth | ~5% | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Life/Health operating profit | 5,700 | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Life/Health CSM release rate | 8–9% | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Asset Management operating profit | 3,500 | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Asset Management cost-income ratio | 61% | pending | confirmed | 28 |
| FY2026 | 2026-03-02 | Corporate and Other operating loss | 800 | pending | confirmed | 28 |
| FY2026 | 2026-02-26 | Operating income | 1–17 | pending | confirmed | 34 |
| FY2025 | 2025-11-14 | Operating profit | 17 | – | raised | 25 |
| FY2025 | 2025-11-13 | Operating income | 17,000 | – | raised | 19 |
| FY2025 | 2025-03-03 | Operating profit | 15,000–17,000 | – | confirmed | 18 |
| FY2025 | 2025-03-03 | Total business volume growth | 6–7% | – | confirmed | 15 |
| FY2025 | 2025-03-03 | Combined ratio | ~93% | – | confirmed | 15 |
| FY2025 | 2025-03-03 | Operating investment result | 2,800 | – | confirmed | 15 |
| FY2025 | 2025-03-03 | Normalized CSM growth | ~5% | – | confirmed | 15 |
| FY2025 | 2025-03-03 | CSM Release Rate | 8–9% | – | confirmed | 15 |
| FY2025 | 2025-03-03 | Cost-income ratio | 61% | – | confirmed | 15 |
| FY2025 | 2025-03-03 | Operating loss | 800 | – | confirmed | 15 |
| FY2024 | 2024-08-08 | Operating profit | 1–14 | – | confirmed | 14 |
| FY2024 | 2024-02-26 | Operating profit | 13,800–15,800 | – | confirmed | 10 |
| FY2024 | 2024-02-26 | Total business volume growth | 5–7% | – | initiated | 7 |
| FY2024 | 2024-02-26 | Combined ratio | 93–94% | – | initiated | 7 |
| FY2024 | 2024-02-26 | Operating profit Property-Casualty | 6,570–8,030 | – | initiated | 7 |
| FY2024 | 2024-02-26 | Operating profit Life/Health | 4,680–5,720 | – | initiated | 7 |
| FY2024 | 2024-02-26 | Operating profit Asset Management | 2,790–3,410 | – | initiated | 7 |
| FY2024 | 2024-02-26 | Core RoE Life/Health | 14–17% | – | initiated | 7 |
| FY2024 | 2024-02-26 | Life/Health total business volume | 73,000–83,000 | – | initiated | 7 |
| FY2024 | 2024-02-26 | Cost-income ratio Asset Management | ~61% | – | initiated | 7 |
| FY2024 | 2024-02-26 | subordinated bond | 1,000 | – | initiated | 7 |
| FY2024 | 2024-02-26 | share buy-back program | 1,000 | – | initiated | 7 |
| FY2023 | 2023-11-10 | operating result | 1–14 | – | confirmed | 6 |
| FY2023 | 2023-08-08 | Operating profit | 13,200–15,200 | – | confirmed | 2 |
Development#
A condensed summary per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. Most recent period first, grouped by year; each text is written from the original report of that period, superscript numbers lead to the source.
FY2026
Allianz SE reported operating profit growth of 8.6% to €9,390 million in the first half of fiscal year 2026, with total revenues rising to €58,751 million from €55,282 million in H1 2025 31. Net income increased to €6,630 million in H1 2026 from €5,599 million in H1 2025, with Q1 2026 contributing 3,690 million and Q2 2026 contributing 2,940 million 31. The Solvency II capitalization ratio strengthened to 225% by end of June 2026 from 218% at year-end 2025, and the Property-Casualty combined ratio for H1 2026 came in at 91.4%, below the full-year guidance range of 92-93% 31 36. Allianz completed the divestiture of its 26% stake in Indian joint ventures BAGIC and BALIC for approximately €2.3 billion and announced agreements to acquire HSBC Life Singapore for a €2.0 billion combined consideration and UOB Asset Management to expand its Asia Pacific presence 31.
FY2025
Allianz Group grew total business volume by 8.1% on an internal basis to EUR 186.9 billion in FY 2025, with all three business segments contributing to the gain 27. Operating profit increased 8.4% to EUR 17,374 million, exceeding the initial full-year target of EUR 16.0 billion plus or minus EUR 1.0 billion 26. Group net income reached 11,430 million, with diluted earnings per share of 27.67, and operating cash flow was 33,209 million 28. The Property-Casualty combined ratio improved to 92.2% from 93.4%, the Solvency II capitalization ratio rose by ten percentage points to 218%, and Asset Management third-party assets under management reached an all-time high of EUR 1,990 billion on net inflows of EUR 139.3 billion 28.
FY2024
Allianz SE grew insurance revenue to 97,675 million in FY2024, with full-year net income rising to 10,540 million, an increase of 16% versus the prior year 15. Operating profit advanced 9% to €16,023 million, exceeding the full-year target of €14.8 billion and marking a record across all three segments – Property-Casualty, Life/Health, and Asset Management 15. Total business volume expanded 11.2% to €179,778 million on internal revenue growth of 11.9%, with the Solvency II capitalization ratio improving to 209% at year-end 15. Operating cash flow reached 31,903 million, and cash and cash equivalents stood at 31,637 million as of 31 December 2024 15. Material portfolio actions during the year included the acquisition of TUA Assicurazioni S.p.A. in Italy and the divestiture of stakes in Allianz Saudi Fransi and Euler Hermes Re S.A. 15.
FY2023
Allianz Group delivered a record operating profit of €14.7 billion in FY2023, up 6.7% from 2022, driven by growth across the Property-Casualty, Life/Health, and Corporate segments, though the third quarter was weighed down by exceptionally high natural catastrophe claims 7 61. Net income attributable to shareholders rose to 9,032 million for the full year, with the improvement partly reflecting higher operating profit, lower income taxes, and the absence of a large Structured Alpha litigation provision that had reduced 2022 net income 7. Insurance revenue grew 4.9% to €91.3 billion, supported by internal business volume growth of 8.0%, while operating cash flow reached 24,462 million 60 7. The Solvency II capitalization ratio improved to 206% at year-end 2023 from 201% at end-2022, and shareholders' equity rose to €58.5 billion 7 58. Core return on equity advanced to 16.0% from 12.7% in 2022, and Allianz completed a €1.5 billion share buyback while raising the proposed dividend by 21.1% to €13.80 per share 61 58.
Glossary#
- Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
- Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
- EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
- EPS adj.: Adjusted earnings per share, verbatim and company-defined (non-GAAP).
- OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
- Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
- *: derived, the formula is in the hover
- ≈: calculated, approximation
- ~: uncertain; the value stays visible, verdicts do not use it
- °: repaired by a targeted query against the document, or curated with documentary evidence
- EBIT: EBIT as a fallback: the income statement carries no operating line
- basic: basic earnings per share as a fallback when diluted is missing
Sources: official investor relations documents#
All original documents used, with type (e.g. quarterly, half-year, annual report), publication date and a direct link to the filing (EDINET/SEC/IR). Every superscript number in the report points to an entry in this list; so every figure can be traced back to its place in the original.
| # | Document type | Published | Link |
|---|---|---|---|
| #3 | IR-Quarter | – | Open |
| #4 | IR-Quarter | – | Open |
| #5 | IR-Quarter | – | Open |
| #7 / #109 | IR-Annual | – | Open |
| #8 | IR-Annual | – | Open |
| #9 | IR-Annual | – | Open |
| #13 | IR-Quarter | – | Open |
| #15 / #119 | IR-Annual | – | Open |
| #16 | IR-Annual | – | Open |
| #17 | IR-Annual | – | Open |
| #20 | IR-Quarter | – | Open |
| #22 | IR-Quarter | – | Open |
| #24 | IR-Quarter | – | Open |
| #26 | IR-Quarter | – | Open |
| #28 / #132 | IR-Annual | – | Open |
| #30 | IR-Annual | – | Open |
| #35 | IR-Quarter | – | Open |
| #39 | IR-Half | – | Open |
| #40 | IR-Half | – | Open |
| #41 | IR-Quarter | – | Open |
| #42 | IR-Half | – | Open |
| #43 | IR-Quarter | – | Open |
| #45 | IR-Report | – | Open |
| #47 | IR-Report | – | Open |
| #48 | IR-Report | – | Open |
| #50 | IR-Report | – | Open |
| #52 | IR-Report | – | Open |
| #54 | IR-Report | – | Open |
| #55 | IR-Report | – | Open |
| #59 | IR-Report | – | Open |
| #61 | IR-Report | – | Open |
| #2 / #102 | IR-Half | 2023-08-08 | Open |
| #1 | IR-Report | 2023-09-26 | Open |
| #6 | IR-Quarter | 2023-11-10 | Open |
| #62 | IR-Report | 2023-12-14 | Open |
| #63 | IR-Report | 2023-12-14 | Open |
| #58 | IR-Report | 2024-02-23 | Open |
| #60 / #170 | IR-Report | 2024-02-23 | Open |
| #11 | IR-Quarter | 2024-05-15 | Open |
| #57 | IR-Report | 2024-05-23 | Open |
| #10 / #112 | IR-Half | 2024-08-07 | Open |
| #12 | IR-Quarter | 2024-08-08 | Open |
| #14 | IR-Quarter | 2024-11-13 | Open |
| #56 | IR-Report | 2024-12-12 | Open |
| #51 | IR-Report | 2025-02-28 | Open |
| #53 / #162 | IR-Report | 2025-02-28 | Open |
| #21 | IR-Quarter | 2025-05-15 | Open |
| #18 / #122 | IR-Half | 2025-08-05 | Open |
| #23 | IR-Quarter | 2025-08-07 | Open |
| #19 | IR-Report | 2025-11-13 | Open |
| #25 | IR-Quarter | 2025-11-14 | Open |
| #49 | IR-Report | 2025-12-11 | Open |
| #27 | IR-Quarter | 2026-02-26 | Open |
| #46 / #154 | IR-Report | 2026-02-26 | Open |
| #29 | IR-Annual | 2026-03-12 | Open |
| #33 | IR-Quarter | 2026-03-31 | Open |
| #34 | IR-Quarter | 2026-05-13 | Open |
| #32 | IR-Report | 2026-07-06 | Open |
| #37 | IR-Report | 2026-07-23 | Open |
| #38 | IR-Report | 2026-07-23 | Open |
| #31 / #135 | IR-Half | 2026-08-05 | Open |
| #36 | IR-Quarter | 2026-08-07 | Open |
Older sources (+1)
| # | Document type | Published | Link |
|---|---|---|---|
| #44 | IR-Report | 2022-07-08 | Open |
FAQ#
Is there a management forecast (guidance) for FY2026?
Yes. Management has issued targets for FY2026, including Operatives Ergebnis. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Which additional key figures does Allianz SE report?
As reported for Q2 2026: Schaden-Kosten-Quote, Neugeschäftsmarge, Für Dritte verwaltetes Vermögen, Eigenkapital, Aufwand-Ertrag-Verhältnis, Schadenquote. The chapter Reported KPIs lists every value with its source. Revenue is broken down by Asset Management, Schaden-Unfall, Life reinsurance, Non-Life – Germany.
Does Allianz SE pay a dividend?
The filings report on the dividend; most recent entry: dividend per share 17.10 (FY2025) (as reported, no assessment of our own). Details with source links are in the report chapters.
Where can I find the official investor relations documents of Allianz SE?
The sources chapter links all 73 original filings used (IR documents) with type, publication date and a direct link; every figure in the report carries a source number.